All conditions

Sleep Disorders

Plain English clinical trial information, updated daily from ClinicalTrials.gov and public government registries. Not medical advice.

4718
Trials on record
597
Recruiting now
9
Australian sites
21
Phase 3 trials
How these figures are counted
  • Trials on record is every trial tagged to this condition at any stage, except those withdrawn before starting or terminated early. Most are completed rather than ongoing, so this is a measure of research history, not of current activity. It is also smaller than the sitewide "trials tracked" figure, which does include withdrawn and terminated trials.
  • Recruiting now counts only trials whose registry status is "Recruiting". Trials listed as not yet recruiting or enrolling by invitation are excluded, so this understates how many may open to new participants soon.
  • Australian sites counts trials counted under "Recruiting now" that list at least one Australian site. A site being listed does not mean it is currently enrolling, and Australian trials registered only on ANZCTR are not counted yet, so this understates local availability.
  • Phase 3 trials counts trials counted under "Recruiting now" that are at Phase 3.

Find recruiting trials for Sleep Disorders →

Get alerts when Sleep Disorders trials change ↗

Voxsanity currently covers 103 conditions. We are expanding coverage regularly.

Understanding Sleep Disorders

A sleep disorder is a condition that affects how well you sleep, how much sleep you get, or how you feel after sleeping. There are many different types, including insomnia (trouble falling or staying asleep), sleep apnoea (where breathing is interrupted during sleep), restless legs syndrome, narcolepsy, and others. Some sleep disorders make you feel exhausted during the day even after a full night in bed, while others cause unusual behaviours or movements during sleep. Sleep disorders are not simply a matter of being a bad sleeper — they are recognised medical conditions that can have real effects on your health, concentration, mood, and daily life.

Sleep disorders are very common in Australia. It is estimated that around 1 in 3 Australians are affected by some form of sleep problem at some point in their lives, making it one of the most widespread health concerns in the country. They can affect people of any age, from children through to older adults, and can occur alongside other health conditions such as anxiety, depression, heart disease, or obesity. Some groups, including shift workers and people with chronic pain, may be at higher risk.

Treatment varies depending on the type of sleep disorder diagnosed. For many people, care is managed by their GP, though some cases are referred to a sleep specialist or a sleep clinic where overnight monitoring may be used to gather more information. Approaches can include changes to sleep habits and routines, devices to assist breathing during sleep, psychological therapies, or medications. A healthcare team will work with the individual to find what suits their particular situation and needs.

This overview is an AI generated summary written from public medical sources and checked on a sample basis. It is general information, not medical advice or a diagnosis. Always speak with your doctor about your situation. How we use AI

Can you access treatment for Sleep Disorders in Australia right now? Here's what's publicly known.

Information on this site does not constitute medical advice. Data is sourced from publicly available government registries. Always consult your doctor before making any health decisions. Trial status should be verified directly with the trial site.

Updated regularly from public government registries

Research pipeline

Where trials for Sleep Disorders currently sit in the development pipeline. The funnel shape shows how few drugs reach later phases in general; the counts are this condition's actual trial numbers.

Phase success rates are industry-wide historical averages, not predictions for specific trials. Learn how trials work →

Most active research sponsors

Organisations with the most recruiting trials for Sleep Disorders.

View sponsor profile
View sponsor profile
View sponsor profile
View sponsor profile
View sponsor profile

Where trials are running

Clinical trial sites for Sleep Disorders by country. Australia is highlighted.

Showing the top 10 of 56 countries with trial sites.

Clinical trials for Sleep Disorders

Showing 602 of 602 trials

The plain English eligibility text on each trial below is an AI generated summary of the official criteria, checked on a sample basis. How we use AI

🇦🇺 NCT00906958 · ResMed Not Applicable · 1 country Completed
Completed Not Applicable Est. completion 15 June 2009
🇦🇺 AU

Who might be able to join this trial: - You are between 18 and 80 years old - You have been using a CPAP machine set to automatic (AutoSet) mode for at least 6 months - You are currently using a ResMed brand mask with your CPAP machine Who may not be able to join: - You are not able to sign a written consent form - Yo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
🇦🇺 NCT02549092 · AbbVie Phase 3 · 9 countries Completed
Completed Phase 3 Est. completion 14 May 2020
🇦🇺 AU🇨🇦 CA🇩🇪 DE🇬🇷 GR🇮🇹 IT🇰🇷 KR🇪🇸 ES🇸🇪 SE +1 more

Who might be able to join this trial: - You must have been diagnosed with idiopathic Parkinson's disease (the most common form of Parkinson's, not caused by another condition) using a specific set of medical guidelines called the UK Parkinson's Disease Society Brain Bank Criteria. - You still have ongoing movement prob...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 NCT04033367 · Sanofi Phase 4 · 10 countries Completed
Completed Phase 4 Est. completion 6 October 2021
🇦🇺 AU🇫🇷 FR🇩🇪 DE🇮🇱 IL🇮🇹 IT🇪🇸 ES🇨🇭 CH🇦🇪 AE +2 more

**Who might be able to join this trial:** - You are a man or woman aged 18 or older who has been diagnosed with long-term (chronic) atopic dermatitis (eczema) - Your eczema has not been well controlled with creams or ointments applied to the skin - Your eczema is considered to be of a certain level of severity, and it...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
🇦🇺 NCT04739423 · CuraSen Therapeutics, Inc. Phase 2 · 3 countries Completed
Completed Phase 2 Est. completion 4 July 2022
🇦🇺 AU🇳🇿 NZ🇬🇧 GB

Who might be able to join this trial: **For people with Parkinson's Disease (PD):** - People aged 40 to 80 years old at the time of agreeing to participate - People who have been diagnosed with Parkinson's Disease (using specific UK brain bank guidelines) along with a sleep condition called REM sleep behavior disorder...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 NCT05262439 · ResMed Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2027
🇦🇺 AU

**Who might be able to join this trial:** - People who are willing to sign a written consent form agreeing to take part - People who can read and understand English - People who are 18 years of age or older - People who have been receiving treatment for obstructive sleep apnea (OSA) for at least 6 months - People who a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
🇦🇺 NCT05978505 · Flinders University Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 July 2025
🇦🇺 AU

**Who might be able to join this trial:** - You are older than 18 years of age - You are scheduled for a planned (non-emergency) surgery on the upper airway (such as the throat, nose, or mouth) - You have been diagnosed with obstructive sleep apnoea (a condition where breathing repeatedly stops and starts during sleep)...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 NCT06567210 · Woolcock Institute of Medical Research Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2029
🇦🇺 AU

Who might be able to join this trial: - People who have been diagnosed with an insomnia disorder, OR who score 10 or higher on a standard insomnia questionnaire (called the Insomnia Severity Index), AND who also score 10 or higher on a standard anxiety questionnaire (called the GAD-7). - People of any sex or gender. -...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
🇦🇺 NCT06769607 · ResMed Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇦🇺 AU

**Who might be able to join this trial:** - You are willing to sign a written consent form to take part in the study - You can read and understand English - You are 18 years of age or older - You currently use a ResMed AirSense 10 or 11 machine - Your device is set to "AutoSet" (automatic pressure adjustment) mode - Yo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
🇦🇺 NCT06801379 · Woolcock Institute of Medical Research Early Phase 1 · 1 country Recruiting
Recruiting Early Phase 1 Est. completion 31 December 2025
🇦🇺 AU

Who might be able to join this trial: - People aged 55 years or older. - People who have been diagnosed with an insomnia disorder, meaning they have had trouble falling asleep, staying asleep, or waking too early at least 3 nights per week for at least 3 months, with at least one daytime problem caused by poor sleep, a...

Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.
🇦🇺 NCT06802913 · Woolcock Institute of Medical Research Early Phase 1 · 1 country Recruiting
Recruiting Early Phase 1 Est. completion 1 December 2025
🇦🇺 AU

Who might be able to join this trial: - People aged 55 years or older. - People who have been diagnosed with insomnia disorder, meaning they have trouble falling asleep, staying asleep, or wake up too early at least 3 nights per week, for at least 3 months, and this affects their daytime functioning — and who score 15...

Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.
🇦🇺 NCT07026175 · Australian Catholic University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2027
🇦🇺 AU

Who might be able to join this trial: - People aged between 18 and 45 years old - People who are well-trained athletes who do sports or exercise that involves being on their feet and bearing weight through their legs (such as running) - People who currently do around 45 kilometres per week of this type of endurance tra...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
🇦🇺 NCT07369011 · Eli Lilly and Company Phase 3 · 12 countries Recruiting
Recruiting Phase 3 Est. completion 1 March 2028
🇦🇷 AR🇦🇺 AU🇧🇷 BR🇨🇦 CA🇨🇳 CN🇩🇪 DE🇮🇳 IN🇯🇵 JP +4 more

**Who might be able to join this trial:** - People who have a confirmed diagnosis of moderate-to-severe obstructive sleep apnea (OSA) - People whose sleep study (done as part of the screening process) shows an AHI score of 15 or higher — this is a measure of how often breathing is interrupted during sleep - People wit...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 NCT07571109 · Novo Nordisk A/S Phase 3 · 10 countries Recruiting
Recruiting Phase 3 Est. completion 26 June 2028
🇦🇺 AU🇨🇳 CN🇩🇪 DE🇮🇳 IN🇯🇵 JP🇵🇱 PL🇪🇸 ES🇹🇼 TW +2 more

**Who might be able to join this trial:** - People who were assigned male or female at birth - People who are 18 years of age or older at the time of signing the consent form - People who have previously been diagnosed with moderate-to-severe obstructive sleep apnea (a condition where breathing repeatedly stops during...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 NCT00519532 · UCB Pharma Phase 3 · 11 countries Terminated
Terminated Phase 3 Est. completion 1 May 2009
🇦🇺 AU🇫🇮 FI🇩🇪 DE🇭🇺 HU🇮🇹 IT🇳🇿 NZ🇵🇱 PL🇿🇦 ZA +3 more

Who might be able to join this trial: - You must have already completed a previous clinical trial called SP889. Who may not be able to join: - You are currently experiencing a serious negative health reaction that is believed to be caused by the medication used in the previous trial (SP889). Important: Always verify...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT00695214 · University of California, Los Angeles Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 June 2035
🇺🇸 US

Who might be able to join this trial: - Adults who have been diagnosed with obstructive sleep apnea (OSA) and are considering surgery as a treatment option Who may not be able to join: - People under 18 years of age - People who are pregnant - People who are not able to give their own consent to participate in English...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT00929006 · University of Virginia Early Phase 1 · 1 country Recruiting
Recruiting Early Phase 1 Est. completion 1 October 2025
🇺🇸 US

**Who might be able to join this trial:** - Girls who are in the middle to later stages of puberty (at least Tanner breast stage 3) and are no more than 2 years past their first period - Girls without signs of excess male hormones: those whose free testosterone level falls within the normal range for their stage of pu...

Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.
NCT01195558 · Vanda Pharmaceuticals Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2030
🇺🇸 US

Who might be able to join this trial: - The person completing the telephone survey (either the participant or their legal guardian) must be at least 18 years old. - Parents or legal guardians may participate on behalf of children aged 0 to 17 years who meet the other criteria. - The person the survey is about must be b...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT02410850 · University of British Columbia Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2026
🇨🇦 CA

Who might be able to join this trial: - People who have been prescribed an oral appliance (a mouth device worn during sleep) by their doctor to treat obstructive sleep apnea. Who may not be able to join: - People who are under 18 years of age. - People who do not understand the English language. - People who are not w...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT02431507 · Michael Harrison Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇺🇸 US

**Who might be able to join this trial:** - People who are between 21 and 70 years of age - People who have been diagnosed with moderate to severe obstructive sleep apnea, meaning their breathing stops or becomes very shallow 15 to 50 times per hour during sleep, as measured by an overnight sleep study - People who ar...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT02573753 · Mayo Clinic Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2031
🇺🇸 US

**Who might be able to join this trial:** - People who are already eligible for and participating in an ongoing study that has been approved by an Institutional Review Board (a committee that oversees research to protect participants) (confirm with trial site) **Who may not be able to join:** - Women who are pregnant...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT02762175 · AZ Sint-Jan AV Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2030
🇧🇪 BE

"Who might be able to join this trial: - People of any age may be considered for this trial - People of any gender may be considered for this trial - People who have been diagnosed with obstructive sleep apnoea syndrome (a condition where breathing repeatedly stops during sleep), confirmed by a sleep test score of 5 or...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT02824822 · Mayo Clinic Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2031
🇺🇸 US

**Who might be able to join this trial:** - Adults between 18 and 50 years old who have been diagnosed with epilepsy, seizures, fainting, drowning, cardiac arrest, sudden death, or who have had an abnormal heart test (ECG) suggesting an irregular heartbeat - Blood relatives (aged 18 or older) of someone who has a histo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT02919930 · Universitaire Ziekenhuizen KU Leuven Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2025
🇧🇪 BE

Who might be able to join this trial: - People who have been diagnosed with central sleep apnea and have not responded to CPAP treatment (a common breathing device used during sleep) - People for whom a type of therapy called ASV (Adaptive Servo-Ventilation, a specialized breathing support device used during sleep) has...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT02945501 · U.S. Army Medical Research and Development Command Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2027
🇺🇸 US

**Who might be able to join this trial:** - People who are healthy men, or women who are not pregnant and not breastfeeding, between 18 and 39 years old (inclusive) - People who are able to show they understand the study rules by scoring at least 80% on a short multiple-choice quiz (one retest is allowed if the first a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03109171 · Fundación Neumologica Colombiana Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2026
🇨🇴 CO

**Who might be able to join this trial:** - Adults aged 18 or older who have been referred to a sleep laboratory at a university hospital for a sleep study to investigate suspected obstructive sleep apnea (a condition where breathing repeatedly stops during sleep). **Who may not be able to join:** - People currently t...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03307330 · Mayo Clinic Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2029
🇺🇸 US

**Who might be able to join this trial:** - People with a body mass index (BMI) of 40 or below - People who do not currently smoke or use tobacco products - People who have been diagnosed with high blood pressure, pre-high blood pressure, or high cholesterol and are receiving treatment for these conditions - People wh...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03457168 · University of Vigo Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2031
🇪🇸 ES

**Who might be able to join this trial:** - Adults aged 18 or older (both men and women) - People whose blood pressure is higher than normal during sleep (specifically, an average sleeping systolic blood pressure of 120 mmHg or more), measured at the time they are enrolled - People who follow a regular routine of being...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03578003 · Portland VA Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇺🇸 US

Who might be able to join this trial: - People who have served in the military as veterans Who may not be able to join: - People who have a history of bipolar disorder - People who have a history of macular degeneration (an eye condition affecting central vision) - People whose primary language is not English - People...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03621566 · Universitaire Ziekenhuizen KU Leuven Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 25 June 2028
🇧🇪 BE

Who might be able to join this trial: - Adults aged 18 years or older - People whose sleep study results show a breathing disturbance score of 15 or more events per hour of sleep, with more than half of those events being non-obstructive in nature (this can be measured from either a diagnostic sleep study or one done w...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03646214 · Texas A&M University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 April 2026
🇺🇸 US

Who might be able to join this trial: - Adults who are pregnant and snore - People who have at least 8 teeth in both the upper and lower jaw - People whose throat and airway opening is rated as relatively unobstructed (Mallampati score I or II — confirm with trial site if unsure) - People whose tonsils are normal or on...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03736382 · Wayne State University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2025
🇺🇸 US

**Who might be able to join this trial:** - People with a body mass index (a measure of body weight relative to height) under 40. - People between 18 and 60 years old. - People recently diagnosed with sleep apnea that has not yet been treated, with a moderate or less severe level of breathing disruptions during sleep...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03767426 · Beth Israel Deaconess Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇺🇸 US

Who might be able to join this trial: - People who are willing and able to follow the study protocol throughout the trial - People who meet the requirements for having an fMRI brain scan (confirm with trial site) - People who are willing to avoid alcohol and recreational drugs for the entire duration of the study - Peo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03777267 · Wake Forest University Health Sciences Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2028
🇺🇸 US

Who might be able to join this trial: - You are able to follow basic instructions and can sit comfortably while wearing some sensor leads attached to your body. - You are experiencing symptoms of stress, anxiety, or sleep problems, and you score at or above a certain level on at least one of the following self-reported...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03811964 · University Hospital, Strasbourg, France Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2027
🇫🇷 FR

**Who might be able to join this trial:** - Adults aged 18 years or older - Men or women - People who have signed a free and informed consent form - People who are part of a social protection scheme (such as health insurance or social security coverage) - People in one of the following groups: those with a primary slee...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03858751 · Brigham and Women's Hospital Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 30 November 2022
🇺🇸 US

**Who might be able to join this trial:** - People who experience more than 10 breathing interruptions per hour during non-REM (lighter stage) sleep while lying on their back, as measured by a sleep study. **Who may not be able to join:** - People who have a medical condition other than well-controlled high blood pres...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT03860233 · Vivek Jain Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 31 December 2026
🇺🇸 US

Who might be able to join this trial: - People who are 18 years of age or older, of any gender Who may not be able to join: - People who are not willing or able to use a CPAP machine (a breathing device worn during sleep) to treat obstructive sleep apnea - People who have other sleep disorders in addition to the condi...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT03948373 · Sociedad Española de Neumología y Cirugía Torácica Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇪🇸 ES

**Who might be able to join this trial:** - Adults aged 18 and over, both men and women - People who have been referred to a sleep clinic because doctors suspect they may have obstructive sleep apnea (OSA) - People who have normal blood pressure and whose sleep study shows a breathing interruption score (AHI) of 30 or...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03954899 · Natalie Denburg Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2025
🇺🇸 US

Who might be able to join this trial: - People between the ages of 56 and 85 years old - People who score 18 or above on a memory and thinking test called the Montreal Cognitive Assessment (MoCA) - People whose level of daily functioning is not significantly affected by memory problems, as measured by a standard rating...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03998020 · University Hospital, Montpellier Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 16 June 2030
🇫🇷 FR

**Who might be able to join this trial:** - People who have been experiencing ongoing, long-term excessive sleepiness, which has been identified by a sleep specialist and requires further objective testing at the Centre de Hypersomnias Rares - People who may or may not have already received a formal diagnosis of a chro...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04031950 · Acurable Ltd. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 October 2025
🇬🇧 GB

Who might be able to join this trial: - Children who are older than one year of age. - Children who have been sent to a sleep clinic because doctors suspect they may have sleep apnoea. Who may not be able to join: - Children whose parents, legal guardians, or carers are not fluent in English, or who have special commu...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04092660 · Queen Mary University of London Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇬🇧 GB

Who might be able to join this trial: - Adults aged 40 years or older - People who have a confirmed diagnosis of obstructive sleep apnoea (a condition where breathing repeatedly stops during sleep), with a test result showing 5 or more breathing interruptions per hour - People who have been referred for treatment with...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04114084 · Michael Tomasson Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 23 May 2030
🇺🇸 US

**Who might be able to join this trial:** - People who have been diagnosed with MGUS (a blood condition where abnormal proteins are found) or Multiple Myeloma (a type of blood cancer) - People who are already scheduled to have a bone marrow biopsy as part of their normal medical care **Who may not be able to join:** -...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04118387 · VA Office of Research and Development Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 31 December 2026
🇺🇸 US

**Who might be able to join this trial:** - People who are military Veterans (men or women) and have been diagnosed with central sleep apnea, meaning their sleep breathing test shows more than 15 breathing pauses per hour overall, with more than 5 of those per hour being the "central" type (where the brain fails to sen...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT04186078 · Seoul National University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2045
🇰🇷 KR

"Who might be able to join this trial: - You may be eligible if you are suspected of having sleep apnea because of symptoms such as snoring, stopping breathing during sleep (noticed by someone else), waking up feeling like you are choking, feeling overly sleepy during the day, not feeling rested after sleep, having tro...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04205370 · University of Michigan Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2027
🇺🇸 US

"Who might be able to join this trial: - People who are at least 28 weeks pregnant - People who are receiving prenatal (pregnancy) care at Michigan Medicine - People who own either an Android or iPhone smartphone Who may not be able to join: - People who are less than 28 weeks pregnant - People who receive their prena...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04303325 · China Medical University, China Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 30 October 2024
🇨🇳 CN

Who might be able to join this trial: - People who are at least 18 years old and have not yet reached menopause - People who are scheduled to have a planned (non-emergency) breast cancer operation - People who have been assessed by a doctor as being in generally good to mild-risk health for anaesthesia (ASA classificat...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT04335994 · Sunnybrook Health Sciences Centre Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇨🇦 CA

**Who might be able to join this trial:** - You have shown signs of memory or thinking problems, based on a score from one of three recognised memory tests (confirm with trial site for specific score ranges) - You have been diagnosed with mild memory problems or dementia possibly related to Alzheimer's disease, reduce...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04399200 · University Hospital, Grenoble Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2030
🇫🇷 FR

**Who might be able to join this trial:** - People aged between 18 and 85 years old, of any sex - People who have been admitted to a stroke unit within 72 hours of their stroke symptoms starting - People whose first-ever stroke has been confirmed by a CT scan or MRI scan, regardless of where in the brain it occurred -...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04400617 · University of Calgary Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇨🇦 CA

**Who might be able to join this trial:** - People who are not very physically active, meaning they do less than 3 sessions per week of vigorous exercise lasting 20 minutes or more - People who are able to move around on their own without using a wheelchair **Who may not be able to join:** - People who have been diagn...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04463498 · Haukeland University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇳🇴 NO

**Who might be able to join this trial:** - People who have been referred to the sleep-school program at Bjørgvin DPS psychiatric hospital - People who meet the recognised diagnostic criteria for insomnia alongside a moderate to severe psychiatric condition, confirmed through standard diagnostic tools used in Norway, i...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04471740 · University of Valencia Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2029
🇪🇸 ES

Who might be able to join this trial: - People whose symptoms and condition are consistent with a diagnosis of normal-pressure hydrocephalus (a condition where fluid builds up in the brain without increased pressure) Who may not be able to join: - People who have cerebrovascular disease (problems affecting the blood v...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04543799 · Oncology Institute of Southern Switzerland Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇨🇭 CH

Who might be able to join this trial: **For people with prostate cancer:** - Men aged 18 or older with prostate cancer that has been confirmed by a tissue sample (biopsy) showing a type called adenocarcinoma - People whose cancer is localised (contained in the prostate), locally advanced, or has spread to other parts...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04557293 · Istituti Clinici Scientifici Maugeri SpA Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 April 2026
🇮🇹 IT

Who might be able to join this trial: - Adults aged 18 or older - People with an Apnea-Hypopnea Index (AHI) score of 15 or more — this is a measure of how many times per hour breathing stops or becomes shallow during sleep (confirm with trial site) Who may not be able to join: - People with a Body Mass Index (BMI) of...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04572503 · Benha University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇪🇬 EG

**Who might be able to join this trial:** - People who have been diagnosed with mild or moderate obstructive sleep apnea (a condition where breathing repeatedly stops during sleep), based on a specific sleep test score between 5 and 30 events per hour - People whose airway blockage during sleep occurs specifically in t...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04588233 · Loma Linda University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2026
🇺🇸 US

Who might be able to join this trial: - You report having trouble sleeping, such as difficulty falling asleep, waking up during the night, or waking up too early. - You are between 13 and 17 years old. - You are able to understand, read, and write in English. - You have never used melatonin before. Who may not be able...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04630535 · St. Anne's University Hospital Brno, Czech Republic Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2028
🇨🇿 CZ

**Who might be able to join this trial:** - People who have a planned (non-emergency) aorto-bifemoral bypass operation scheduled, which is a surgery to reroute blood flow around a blocked section of the main abdominal artery down to the legs **Who may not be able to join:** - People who need emergency surgery rather t...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04632628 · University of South Florida Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2027
🇺🇸 US

**Who might be able to join this trial:** **For caregivers:** - People aged 18 or older - People who care for someone with dementia and live with that person - People who are willing to be randomly assigned to a treatment group - People who can read and understand English - People who have been diagnosed with insomnia...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04652882 · Vanda Pharmaceuticals Phase 3 · 3 countries Recruiting
Recruiting Phase 3 Est. completion 1 June 2026
🇦🇹 AT🇩🇪 DE🇺🇸 US

**Who might be able to join this trial:** - People who are willing and able to give written consent to participate. - People who have been clinically diagnosed with Delayed Sleep-Wake Phase Disorder (DSWPD), a condition where a person's sleep timing is significantly shifted later than normal. - People between the ages...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT04658290 · Chinese University of Hong Kong Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 28 August 2026
Hong Kong

**Who might be able to join this trial:** - People whose current medications have been stable for at least 4 weeks, where those medications are ones known not to affect sleep patterns or the body's internal clock. **Who may not be able to join:** - People who are suspected to have dementia, or who score below 24 on a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04659291 · Chinese University of Hong Kong Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 29 August 2028
Hong Kong

Who might be able to join this trial: - People who are suspected of having obstructive sleep apnea (a condition where breathing repeatedly stops and starts during sleep) - People aged 18 or older - People who can speak, read, and understand Chinese or English - People who are able to answer questions and follow instruc...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04675268 · Universitaire Ziekenhuizen KU Leuven Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2025
🇧🇪 BE

Who might be able to join this trial: - Adults who are suspected of having obstructive sleep apnoea (a condition where breathing repeatedly stops during sleep) and who have been recommended to have a sleep study (polysomnography) Who may not be able to join: - People under 18 years of age - People who are unable to re...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04723862 · University of Virginia Early Phase 1 · 1 country Recruiting
Recruiting Early Phase 1 Est. completion 1 October 2025
🇺🇸 US

**Who might be able to join this trial:** - Girls aged 10 to 17 years who are in the middle or later stages of puberty, based on breast development stage and/or whether their periods have started. - Girls who have higher-than-normal levels of male hormones (such as testosterone) for their stage of puberty, or who have...

Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.
NCT04725617 · University of Arizona Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 28 September 2025
🇺🇸 US

Who might be able to join this trial: - People aged 18 to 75 years, of any gender - People who have a confirmed HIV diagnosis - People whose CD4+ T cell count (a measure of immune system health) is at least 200 cells/mm³ - People who are either on a stable HIV medication regimen with no plans to change it, or not curre...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04770116 · University Children's Hospital, Zurich Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 March 2026
🇨🇭 CH

**Who might be able to join this trial:** - People who have signed a consent form agreeing to take part - Children and teenagers between 6 and 18 years old - Patients (and at least one of their legal guardians or parents) who have a good understanding of German - Patients who came to the Emergency Department at the Uni...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04817163 · CHU de Quebec-Universite Laval Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 May 2025
🇨🇦 CA

Who might be able to join this trial: - People who have been diagnosed with cancer that has not spread to other parts of the body (any cancer type) - People aged 18 years or older - People who can read and understand French or English without difficulty - People who have the basic mental ability to read, understand, an...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04831385 · Chinese University of Hong Kong Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2026
Hong Kong

**Who might be able to join this trial:** - You are 60 years old or older - You have type 2 diabetes with blood sugar levels that are not well controlled (based on a specific blood test result, called HbA1c, falling between 7.1% and 10%) - You are of Chinese ethnicity - You have sleeping problems (insomnia), based on a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04855630 · University of Miami Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2028
🇺🇸 US

Who might be able to join this trial: - People who are able to do light physical activity, such as a gentle walk - People who are able to wear a headband device while sleeping (called the DREEM 2 Headband) - People who are able to wear a Fitbit-style wristwatch - People who are able to complete a home finger-prick bloo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04943562 · SleepUp Tecnologia em Saúde Ltda Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 12 December 2021
🇧🇷 BR

**Who might be able to join this trial:** This trial has two stages, each looking for different types of volunteers. **Stage 1 – Healthy volunteers:** - You are between 20 and 80 years old - You currently live in São Paulo, Brazil - You do not have any physical or intellectual disability that would stop you from atte...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04953559 · University of Arizona Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 August 2022
🇺🇸 US

**Who might be able to join this trial:** - People who are men, or women who are not pregnant or breastfeeding, aged 18 to 50 years old, and who are free from certain health conditions, medications, or devices that would prevent participation. - People whose sleep trouble meets the criteria for primary insomnia, as sh...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04962087 · IWK Health Centre Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇨🇦 CA

**Who might be able to join this trial:** - People who are 18 years of age or older - People who experience at least one insomnia symptom (such as trouble falling asleep, waking during the night, or waking too early) at least 3 times per week, for at least 3 months - People who have access to an internet-connected devi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04966351 · Colorado State University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2026
🇺🇸 US

**Who might be able to join this trial:** - People aged 18 to 35 years old, both men and women (with equal numbers of each) - People with a Body Mass Index (BMI) between 20.0 and 24.9, which is considered a "normal" weight range - People who are either not regularly active or only moderately active on a habitual basis...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04989790 · Johns Hopkins University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 11 August 2025
🇺🇸 US

"Who might be able to join this trial: - Children who have been on a breathing machine (mechanical ventilator) through a tube placed in the mouth or nose for at least 48 hours by 7 a.m. on the third day in the Pediatric Intensive Care Unit (PICU) Who may not be able to join: - Children for whom life support is current...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04991389 · Children's Hospital Medical Center, Cincinnati Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 September 2027
🇺🇸 US

**Who might be able to join this trial:** - Children and teenagers between the ages of 5 and 18 (for one part of the study involving xenon gas imaging), or between the ages of 3 and 18 (for other parts of the study) - Children who still have moderate or severe sleep apnea after having their tonsils and adenoids remove...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT05011331 · Rhode Island Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇺🇸 US

Who might be able to join this trial: - People who are older than 18 years of age and have been diagnosed with rotator cuff syndrome that is being treated without surgery. Who may not be able to join: - People who have had previous surgery on their shoulder. - People who are receiving a corticosteroid (steroid) inject...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05011877 · Unity Health Toronto Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2026
🇨🇦 CA

Who might be able to join this trial: - Adults who have been admitted to hospital or visited an emergency room unexpectedly due to a sudden episode of breathing failure where too much carbon dioxide builds up in the blood (confirm with trial site) - People who do not currently use a breathing support machine (such as C...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05044520 · University Hospital, Montpellier Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2026
🇫🇷 FR

"Who might be able to join this trial: - You must be an adult (18 years or older) - You must have been diagnosed with Restless Legs Syndrome - You must be a member of the Restless Legs Syndrome association - You must speak French - You must be able to understand what the study involves - You must be willing and able to...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05059158 · Ludwig-Maximilians - University of Munich Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2025
🇩🇪 DE

**Who might be able to join this trial:** - You have been diagnosed with either mild memory problems (amnestic MCI), Alzheimer's disease dementia, or have been assessed as clinically normal - You are able to read and sign a consent form agreeing to take part - Your medications have not changed in the 4 days before the...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05115968 · Chinese University of Hong Kong Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
Hong Kong

Who might be able to join this trial: - Chinese children between 6 and 11 years old who snore regularly (at least 3 nights per week) and have been diagnosed with obstructive sleep apnoea (a condition where breathing repeatedly stops during sleep) confirmed by an overnight sleep study, along with enlarged tonsils and ad...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05124392 · Massachusetts General Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2027
🇺🇸 US

**Who might be able to join this trial:** - People aged 18 to 85 years old - People who meet at least one of the following: they are a known carrier of a specific genetic mutation (in the PRNP gene); they have a biological parent and other family members who have had a prion disease diagnosis; or they are a family mem...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05125146 · Dr. Nazanin Alavi Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 21 May 2025
🇨🇦 CA

Who might be able to join this trial: - People who are at least 18 years old at the time the study begins - People who have insomnia that is not caused by another medical condition (sometimes called "non-organic insomnia") (confirm with trial site) - People who have trouble falling asleep and/or staying asleep, with th...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05145764 · Johns Hopkins University Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 August 2026
🇺🇸 US

**Who might be able to join this trial:** - People aged 18 to 65 years old - People who have been diagnosed with opioid use disorder (a problematic pattern of opioid use) according to standard medical criteria, with signs of physical dependence on opioids - People whose urine test shows the presence of fentanyl or a si...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05147649 · CHU de Reims Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 2 January 2027
🇫🇷 FR

**Who might be able to join this trial:** - People who have been diagnosed with severe obstructive sleep apnea (a condition where breathing repeatedly stops during sleep), with a score of more than 30 breathing interruptions per hour, and who are not currently using a CPAP machine (a breathing device used during sleep...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05176132 · Claus Bogh Juhl Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2025
🇩🇰 DK

Who might be able to join this trial: - You are between 18 and 60 years old - Your Body Mass Index (BMI) falls into one of these groups: over 30 (the main study group), between 20 and 25 (comparison group 1), or between 25 and 30 (comparison group 2) Who may not be able to join: - There are no listed reasons that woul...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05184933 · Oregon Health and Science University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 March 2028
🇺🇸 US

Who might be able to join this trial: - People aged between 25 and 64 years old - People with a body mass index (a measure of body weight relative to height) between 18.5 and 42 - People with high blood pressure, where resting blood pressure readings average between 130/80 mmHg and 160/100 mmHg Who may not be able to...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05193136 · National Hospital Organization Minami Kyoto Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇯🇵 JP

Who might be able to join this trial: - People who have been diagnosed with COPD (a lung condition that makes it hard to breathe) or IPF (a condition where the lungs become scarred over time) Who may not be able to join: - People who have been admitted to hospital for a serious breathing problem in the last month befo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05197738 · Scripps Translational Science Institute Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇺🇸 US

**Who might be able to join this trial:** - People who are 18 years of age or older - People who are currently living in the United States - People who are able to use the REFRESH app on their own personal smartphone **Who may not be able to join:** - People who are unable to give their own informed consent to partici...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05209438 · Wake Forest University Health Sciences Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2027
🇺🇸 US

**Who might be able to join this trial:** - People who provide at least 10 hours of caregiving per week (any type of caregiving counts) - People who are willing to give their informed consent to participate - People who are able to follow basic instructions - People who are able to sit comfortably for up to 90 minutes...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05224193 · University Hospital Southampton NHS Foundation Trust Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2022
🇬🇧 GB

Who might be able to join this trial: - Children and teenagers between 6 and 18 years old - People who have been diagnosed with Inflammatory Bowel Disease (IBD), confirmed through a camera examination of the gut and/or tissue testing - People who are receiving care from the paediatric (children's) gastroenterology team...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05262543 · University of Cagliari Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 March 2025
🇮🇹 IT

Who might be able to join this trial: - People who are 18 years of age or older - People who have been diagnosed with a sleep condition called Isolated REM Sleep Behavior Disorder (iRBD), based on specific international diagnostic guidelines Who may not be able to join: - People who are unable to give or take back the...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05282550 · Johns Hopkins University Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 30 July 2027
🇺🇸 US

**Who might be able to join this trial:** - You have been diagnosed with Mild Cognitive Impairment (MCI), meaning you have memory concerns reported by yourself and/or shown through testing - Your memory impairment has been rated as mild on a standard assessment called the Clinical Dementia Rating scale (score of 0.5,...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05294991 · The University of Texas Health Science Center at San Antonio Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 October 2026
🇺🇸 US

**Who might be able to join this trial:** - People who have a blood cancer diagnosis and whose treatment has been stable (no changes to cancer-related medications in the past two weeks), whether on a steady medication plan or under observation - People who are not currently taking part in another clinical trial that in...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05303987 · Erin Kirkham Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 January 2027
🇺🇸 US

Who might be able to join this trial: - The child has been diagnosed with obstructive sleep apnea (a condition where breathing repeatedly stops during sleep), confirmed by an overnight sleep study done in an accredited sleep laboratory within the past 12 months. - A qualified ear, nose, and throat (ENT) specialist has...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05309473 · Walter Reed Army Institute of Research (WRAIR) Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2025
🇺🇸 US

**Who might be able to join this trial:** - Men and women (who are not pregnant or breastfeeding) between 18 and 39 years old - People who can show they understand the study by scoring at least 80% on a short multiple-choice quiz (one retest is allowed if the first attempt is unsuccessful) **Who may not be able to joi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05315752 · Centre Hospitalier Universitaire Saint Pierre Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇧🇪 BE

Who might be able to join this trial: - People who meet the criteria for bariatric (weight loss) surgery, meaning they have a BMI of 35 or above with health complications related to their weight, or a BMI of 40 or above, and have not lost enough weight through diet and physical activity changes alone - People who have...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05336084 · University of Pittsburgh Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 March 2030
🇺🇸 US

Who might be able to join this trial: - People who are between 13 and 18 years old - People who are currently attending a traditional in-person high school (note: school closures during the COVID-19 pandemic are considered an exception to this requirement) - People who are in good physical and mental health - People (a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05336890 · Ann & Robert H Lurie Children's Hospital of Chicago Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2026
🇺🇸 US

Who might be able to join this trial: - People who were previously enrolled in the Pre-Vent Study under an approved research protocol, either by signing a consent form or under a protocol that allowed being contacted again for future research - People who were born before 29 weeks of pregnancy (very premature birth) -...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05340881 · Baylor College of Medicine Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇺🇸 US

**Who might be able to join this trial:** - You were diagnosed with a brain tumor and received treatment at Texas Children's Hospital - Your treatment included surgery alone, or surgery combined with proton beam radiation therapy - Your brain tumor was not one of the following types: high-grade glioma, brain stem gliom...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05350332 · Emory University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇺🇸 US

Who might be able to join this trial: - Adults aged 18 or older who are willing and able to give their informed consent to participate - People who have been diagnosed with obstructive sleep apnea, with a breathing interruption score of 5 or more events per hour - People who are interested in surgical treatments for ob...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05402280 · University of Ostrava Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2025
🇨🇿 CZ

Who might be able to join this trial: - People who are 18 years of age or older - People who have been in hospital for longer than 24 hours - People who have been in hospital for longer than 36 hours - People who have been in hospital for at least 72 hours, do not have a history of sleep problems, and do not have any c...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05414357 · Centre Francois Baclesse Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2027
🇫🇷 FR

**Who might be able to join this trial:** - People aged between 39 and 69 years old - People who have had surgery for breast cancer that has not spread, and who may or may not be starting chemotherapy after surgery - People who have completed at least the end of primary school education - People who have a good level...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05414708 · Walter Reed National Military Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇺🇸 US

**Who might be able to join this trial:** - People who are eligible in the Defense Enrollment Eligibility Reporting System (DEERS) (confirm with trial site) - People who are currently serving in the military (Active Duty) or veterans who left the military within the past 10 years - People with significant post-traumati...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05429983 · Johns Hopkins University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 29 November 2027
🇺🇸 US

Who might be able to join this trial: - People (male or female) who have moderate or severe sleep apnea, meaning they stop breathing or have very shallow breathing more than 15 times per hour during sleep. - People who are already scheduled to have a procedure called DISE (a sleep evaluation where a camera is used to l...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05435794 · ResMed Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 October 2022
🇫🇷 FR

**Who might be able to join this trial:** - People who are already taking part in the SunSAS study, or people who have had a sleep breathing test (polygraphy or polysomnography) that showed they are suitable for treatment with a CPAP machine or a mouth device (MAD) for obstructive sleep apnoea (OSA) - People who have h...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05451524 · Chinese University of Hong Kong Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 April 2026
Hong Kong

Who might be able to join this trial: - People aged between 15 and 24 years old (as defined by the World Health Organization) - People who are willing to provide written agreement to take part, and for those under 18, a parent or guardian must also give written agreement - People who have mild sleep difficulties — expe...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05452031 · University of California, Los Angeles Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 May 2027
🇺🇸 US

**Who might be able to join this trial:** **For the person living with dementia:** - A doctor has documented a diagnosis of Alzheimer's disease or a related dementia in their medical records - Living in the community (not in a care facility) - Aged 60 years or older - Experiencing more than one sleep problem more than...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05456607 · University of Rochester Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 March 2027
🇺🇸 US

Who might be able to join this trial: - You speak English as your primary language - You are a U.S. Military Veteran - You are experiencing depression, based on scoring above 10 on a standard depression questionnaire (called the PHQ) - You are experiencing insomnia (sleep problems), based on scoring above 10 on a stand...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05459935 · University of Alberta Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 6 July 2026
🇨🇦 CA

Who might be able to join this trial: - You have large tonsils that a doctor has rated as a 3 or 4 on a standard size scale (called the Brodsky scale) - The child agrees and the parent or guardian gives their permission to take part in all check-ups before and after the study, including sleep tests - Both the child and...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05471960 · University of Minnesota Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 July 2027
🇺🇸 US

Who might be able to join this trial: **For people with iRBD (a sleep behaviour disorder):** - People who have been diagnosed with isolated RBD (a sleep disorder where people act out their dreams), confirmed by a sleep study called a polysomnogram. - People who are able to walk 50 metres on their own without using a w...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05473689 · University Health Network, Toronto Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 July 2025
🇨🇦 CA

**Who might be able to join this trial:** - Adults aged 18 or older who speak English - People who have had a spinal cord injury in the neck or mid-back region (between levels C2 and T12) within the last 30 days - People whose spinal cord injury may be complete or partial (a range of severity levels are included) - Peo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05474846 · M.D. Anderson Cancer Center Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 28 February 2027
🇺🇸 US

**Who might be able to join this trial:** - People who have had poor sleep quality for at least 2 weeks, with a score of 5 or higher on a standard sleep quality questionnaire called the PSQI - People who are able to communicate in English - People who are mentally alert enough to answer questions clearly, as measured...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05475262 · Scripps Health Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2025
🇺🇸 US

Who might be able to join this trial: - People who are over 18 years old - People who are admitted to a hospital internal medicine ward for at least 3 nights Who may not be able to join: - No specific exclusion criteria have been listed for this trial (confirm with trial site) Important: Always verify eligibility wit...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05497180 · University of Alberta Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 1 July 2026
🇨🇦 CA

**Who might be able to join this trial:** - People who have been diagnosed with mild obstructive sleep apnea or with snoring that is not related to sleep apnea - People who are 18 years of age or older - People who are able to give their informed consent to receive treatment and take part in the study **Who may not be...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05499741 · University of California, Los Angeles Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2026
🇺🇸 US

**Who might be able to join this trial:** - People who have been diagnosed with Tourette's disorder according to DSM-5 criteria (a standard diagnostic guide used by clinicians) - People who have also been diagnosed with Insomnia disorder according to DSM-5 criteria - People whose tic severity scores meet a minimum thr...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05500170 · State University of New York at Buffalo Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 August 2027
🇺🇸 US

**Who might be able to join this trial:** - People who score above 5 on a standard sleep quality questionnaire called the Pittsburgh Sleep Quality Index, which suggests they are experiencing poor sleep **Who may not be able to join:** - People who score below 20 on a memory and thinking assessment called the VA-SLUMS...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05505188 · University Hospital, Caen Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2026
🇫🇷 FR

**Who might be able to join this trial:** - People who have been diagnosed with head and neck cancer for the first time, where their treatment plan includes radiotherapy - People aged 18 or older - People who have given written agreement to take part - People who have not previously had radiotherapy - People with a li...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05508971 · Oregon Health and Science University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇺🇸 US

**Who might be able to join this trial:** - The child has been diagnosed with Down syndrome (Trisomy 21) - The child has been diagnosed with moderate to severe obstructive sleep apnea (OSA), confirmed by a sleep study showing a specific level of breathing disruptions during sleep (oAHI of 5 or higher) - The child is b...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05524922 · Fujian Medical University Union Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2030
🇨🇳 CN

**Who might be able to join this trial:** - You have been diagnosed with a neurodegenerative disease (a condition where nerve cells in the brain gradually break down, such as Alzheimer's or Parkinson's disease). - You experience insomnia, excessive sleepiness during the day, or confusion at night. - You frequently wak...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05536076 · VA Office of Research and Development Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 28 February 2027
🇺🇸 US

**Who might be able to join this trial:** - Adults who had a spinal cord injury or disease more than 6 months ago, with any level of injury severity (classified A through D on a standard spinal injury scale), and who show signs of a sleep breathing disorder - People without a spinal cord injury who have been diagnosed...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05539716 · University of Miami Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2027
🇺🇸 US

**Who might be able to join this trial:** *For the first part of the study (Aim 1):* - You are between 18 and 70 years old - You are able to read and agree to a consent form *For the second part of the study (Aim 2), all of the above, plus:* - You have moderate-to-severe sleep apnea, meaning your breathing stops or i...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05551325 · Yale University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 29 June 2029
🇺🇸 US

**Who might be able to join this trial:** - You are 18 years old or older - You are seriously ill and admitted to the Medical Intensive Care Unit (MICU) and need a breathing machine, breathing support through a mask or high-flow oxygen through the nose, or medications to support your blood pressure - You were admitted...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05565833 · University of Virginia Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 January 2028
🇺🇸 US

**Who might be able to join this trial:** - People who are willing to sign and date a consent form agreeing to take part - People who are willing to follow all study procedures and are available for the full duration of the study - People who are male or female, aged 65 years or older - People who can speak and read En...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05575401 · Loma Linda University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇺🇸 US

Who might be able to join this trial: - Children and teenagers between 3 and 17 years old who are having their tonsils removed (with or without their adenoids removed) at Loma Linda University Health Who may not be able to join: - Children who have a condition they were born with that affects their development, or who...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05576090 · University of California, Los Angeles Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2026
🇺🇸 US

Who might be able to join this trial: - People who are in their first or second year of undergraduate study at UCLA - People between 18 and 22 years old - People who are currently living in the residential halls on the UCLA campus - People who score 8 or above on a standard sleep questionnaire called the Insomnia Sever...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05589753 · VA Office of Research and Development Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 31 December 2026
🇺🇸 US

**Who might be able to join this trial:** - You are a Veteran between 18 and 89 years old - You have been prescribed opioid medication by a doctor **Who may not be able to join:** - Your body mass index (a measure of body weight relative to height) is over 40 (confirm with trial site) - You have a heart condition that...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05618002 · Salem Anaesthesia Pain Clinic Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 11 December 2025
🇨🇦 CA

**Who might be able to join this trial:** - Adults living with chronic (long-term) pain - People who have shown good adherence to their treatment plans - People with severe, long-term difficulty sleeping (chronic insomnia) - People for whom non-medication sleep therapies (such as sleep hygiene or talking therapies) hav...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05623137 · The Hong Kong Polytechnic University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2025
Hong Kong

Who might be able to join this trial: - People aged between 55 and 85 years old - People who have been diagnosed with a stroke (confirmed by MRI or CT scan) more than one year ago - People who are able to walk at least 6 metres on their own without assistance - People who score between 18 and 27 on a standard memory an...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05649514 · University Hospital, Montpellier Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2027
🇫🇷 FR

**Who might be able to join this trial:** - You have been diagnosed with mild Alzheimer's disease, with a memory test score between 21 and 30 out of 30 - You are either not taking Alzheimer's medications (such as donepezil or memantine), or you have been on a stable dose of these medications for at least 3 months - You...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05663034 · Johns Hopkins University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2027
🇺🇸 US

**Who might be able to join this trial:** - You are currently serving or have previously served in the military or other uniformed services - You have been diagnosed with a traumatic brain injury (TBI) that meets the criteria set by the Veterans Affairs or Department of Defense - Your TBI happened more than 90 days ago...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05674357 · Massachusetts General Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2028
🇺🇸 US

Who might be able to join this trial: **For cancer patients:** - Adults aged 18 or older - Currently receiving cancer treatment or follow-up care at the MGH Cancer Center - Scores above 3 on a standard distress rating scale (the NCCN Distress Thermometer) - Reports that their distress or main concern is connected to t...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05678088 · Sunnybrook Health Sciences Centre Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇨🇦 CA

**Who might be able to join this trial:** - People who have been diagnosed with obstructive sleep apnea (OSA), where breathing repeatedly stops or is reduced during sleep, with a severity score of 10 or more events per hour — and where more than half of those events are caused by the airway being blocked (rather than...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05682144 · Immusoft of CA, Inc. Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 1 June 2029
🇺🇸 US

Who might be able to join this trial: - People who have been diagnosed with Mucopolysaccharidosis type I Hurler-Scheie or Scheie syndrome. - People who are 10 years of age or older at the time of registering for the study. - People whose kidneys are functioning well enough, as shown by a kidney filtering rate above a c...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05683145 · VA Eastern Colorado Health Care System Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2026
🇺🇸 US

Who might be able to join this trial: - People who have had a moderate to severe traumatic brain injury at least one year ago - People who are currently experiencing insomnia (ongoing trouble sleeping) - People who have reliable access to the internet - People who are able to give informed consent to participate Who m...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05684094 · University of Oregon Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 28 February 2027
🇺🇸 US

**Who might be able to join this trial:** - People who are between 18 and 24 years old - People who drink alcohol at high-risk levels in the past month — for women, this means 4 or more drinks in a day or 8 or more drinks per week; for men, 5 or more drinks in a day or 15 or more drinks per week - People whose sleep o...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05701969 · University of Virginia Early Phase 1 · 1 country Recruiting
Recruiting Early Phase 1 Est. completion 30 June 2028
🇺🇸 US

Who might be able to join this trial: - People who are in their first through fifth year after completing medical school (Post-Graduate Year 1–5) - People currently enrolled in a residency program in anesthesiology, general surgery, obstetrics and gynecology, general medicine, or pediatrics at the University of Virgini...

Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.
NCT05710991 · St. Joseph's Healthcare Hamilton Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2025
🇨🇦 CA

Who might be able to join this trial: - People who are 18 years of age or older - People who are currently pregnant and up to 34 weeks along (first, second, or third trimester) - People who are experiencing sleep difficulties, indicated by a score of 8 or higher on a standard sleep questionnaire called the Insomnia Sev...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05715411 · University Hospital, Strasbourg, France Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇫🇷 FR

**Who might be able to join this trial:** - People aged between 30 and 60 years old - People who have been diagnosed with an insomnia disorder and take more than 30 minutes to fall asleep at least 3 nights per week - People who are able to understand the goals and risks of the research and can provide written, signed,...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05726890 · Ben-Gurion University of the Negev Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2027
🇮🇱 IL

Who might be able to join this trial: - The child has been diagnosed with early-childhood insomnia based on DSM-5 criteria (a standard set of diagnostic guidelines) - The parents want the child to be able to fall asleep and stay asleep without much help, and prefer to sleep separately from the child - The family has tw...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05735444 · Shanghai Jiao Tong University School of Medicine Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇨🇳 CN

**Who might be able to join this trial:** - People who agree to take part and sign a consent form - People who are at least 18 years old - People who score 3 or more points on a screening tool called the STOP-Bang questionnaire, which checks for signs of sleep apnoea - People who have completed an overnight sleep study...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05739617 · National Cheng-Kung University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 20 May 2026
🇹🇼 TW

Who might be able to join this trial: - People who have recently been diagnosed with obstructive sleep apnea (OSA), with a sleep test result showing 5 or more breathing interruptions per hour - People aged between 20 and 65 years old - People with a body mass index (a measure of body weight relative to height) between...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05742776 · Afyonkarahisar Health Sciences University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2026
Turkey (Türkiye)

Who might be able to join this trial: - People who have been diagnosed with carpal tunnel syndrome (a condition causing pain, numbness, or tingling in the hand and wrist) using the diagnostic standards set by the American Academy of Neurology Who may not be able to join: - People who have nerve problems in the neck, s...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05759065 · Brigham and Women's Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2027
🇺🇸 US

**Who might be able to join this trial:** - People who are 18 years of age or older - People who have been diagnosed with insomnia based on standard medical diagnostic criteria (DSM-5) - People whose insomnia severity score is greater than 10 on a standard measurement scale - People who receive healthcare through a pu...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05775627 · Oregon Health and Science University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2027
🇺🇸 US

Who might be able to join this trial: - Adults between 18 and 40 years of age - People who are not currently using any drugs (including caffeine, nicotine, alcohol, and herbal medications) - People who have been confirmed by a doctor to be free of disease Who may not be able to join: - People who do not eat or cannot...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05780814 · Johns Hopkins University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2028
🇺🇸 US

**Who might be able to join this trial:** - People who are female and aged 18 or older - People who have been diagnosed with a specific type of early-stage breast cancer (called Ductal Carcinoma In Situ or stage I–III invasive breast cancer), confirmed through a tissue sample test - People whose general physical funct...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05790330 · King's College London Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇬🇧 GB

Who might be able to join this trial: - People aged 12 to 18 who have been diagnosed with atopic eczema by a Consultant Dermatologist, or healthy individuals without eczema (as a comparison group). - People with atopic eczema whose condition requires treatment that works through the immune system, or those currently ma...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05806450 · Sungshin Women's University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 11 June 2025
🇰🇷 KR

**Who might be able to join this trial:** - People who are the main nighttime caregiver (mother or father) of a healthy baby or toddler aged 6 to 24 months, born at full term, with no twin or multiple birth - Caregivers who are between 19 and 65 years old - Caregivers who are native Korean speakers, meaning they can l...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05808179 · Stanford University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 20 June 2026
🇺🇸 US

Who might be able to join this trial: - People aged 14 to 18 who are currently enrolled as a full-time student in grades 9 through 12 - People of any gender - People who are willing and have a schedule that allows them to go to bed earlier than they currently do - People who plan to sleep at home in their own bedroom f...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05814055 · University of Florida Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 31 January 2027
🇺🇸 US

**Who might be able to join this trial:** - Adults between 21 and 75 years old - People who report smoking at least 5 cigarettes per day for the past year and want to quit at the time of screening - People whose breath test shows a carbon monoxide level above 8 ppm at the time of recruitment - People who are willing t...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05816304 · University Health Network, Toronto Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2024
🇨🇦 CA

Who might be able to join this trial: - People who work in healthcare and have likely insomnia, shown by a score of 16 or lower on a sleep assessment tool called the Sleep Condition Indicator (SCI) - People who consider themselves frontline healthcare workers involved in directly managing patients - People who have acc...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05823844 · Columbia University Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 May 2025
🇺🇸 US

Who might be able to join this trial: - You are between 50 and 90 years old. - You are scheduled for a planned (non-emergency) surgery such as hip or knee replacement, hernia repair, kidney cancer surgery, urologic, gynecologic, or spine surgery, and you are expected to stay in the hospital for at least 24 hours afterw...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT05837091 · Mayo Clinic Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 29 January 2027
🇺🇸 US

**Who might be able to join this trial:** - People who have been diagnosed with Idiopathic Hypersomnia (a condition causing excessive sleepiness) based on recognised medical guidelines - People aged between 18 and 65 years - People whose body mass index (a measure of body weight relative to height) falls between 18 an...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT05842863 · Stanford University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2026
🇺🇸 US

**Who might be able to join this trial:** - People aged 12 to 18 who have not yet finished high school - People who have sleep problems, based on a score of 8 or higher on a standard sleep difficulty questionnaire called the Insomnia Severity Index - People who have had more than 3 episodes of self-harm in their lifeti...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05850676 · University of Pennsylvania Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 May 2026
🇺🇸 US

**Who might be able to join this trial:** - People between the ages of 21 and 55 (male or female) - People who have been diagnosed with Idiopathic Hypersomnia (a condition causing excessive daytime sleepiness without a clear cause) or Hypersomnia linked to a psychiatric disorder, based on standard diagnostic criteria -...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05881031 · The Hospital for Sick Children Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇨🇦 CA

**Who might be able to join this trial:** - Children and teenagers between the ages of 5 and 17 years old - Children who have just been prescribed a non-invasive breathing support machine (a mask-based device that helps with breathing, often used during sleep) - Children who have already tried using the breathing devic...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05905705 · Washington University School of Medicine Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 July 2027
🇺🇸 US

Who might be able to join this trial: - People who have been referred for their first course of electroconvulsive therapy (ECT) for depression that has not responded to other treatments, including those with unipolar major depression or bipolar depression - People whose depression is considered treatment-resistant, mea...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05908591 · University of Alberta Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 18 April 2027
🇨🇦 CA

Who might be able to join this trial: - People who are over 18 years of age - People who are pregnant and between 20 and 24 weeks along at the time of joining the trial Who may not be able to join: - People who have worked shifts past 11pm at any point in the month before joining the trial - People who have been diagn...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05911646 · Connecticut Children's Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 October 2026
🇺🇸 US

Who might be able to join this trial: - The parent or caregiver of a child who has been recently diagnosed with mild obstructive sleep apnea, meaning a sleep study showed an AHI score (a measure of breathing interruptions during sleep) between 1 and 5 - The parent or caregiver of a child who is between 3 and 12 years o...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05917119 · VA Office of Research and Development Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 May 2027
🇺🇸 US

**Who might be able to join this trial:** - People who have been formally diagnosed with obstructive sleep apnea (OSA). - People who have been using a CPAP or BiPAP breathing machine for at least 3 months, wearing it for more than 6 hours a night on at least 75% of nights, and whose sleep apnea is well controlled on th...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05918120 · Sunnybrook Health Sciences Centre Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇨🇦 CA

Who might be able to join this trial: - People who have high blood pressure, either not fully controlled (whether or not they are taking medication), or controlled but requiring two or more blood pressure medicines to keep it under control. - People considered at high risk for obstructive sleep apnea (a condition where...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05935241 · Johns Hopkins University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 May 2029
🇺🇸 US

Who might be able to join this trial: - People who report having difficulty sleeping - People who are not currently physically active or do not exercise regularly - People with a low household income - People who are physically able to do moderate-intensity exercise (such as brisk walking) Who may not be able to join:...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05939453 · Maimonides Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇺🇸 US

Who might be able to join this trial: - People who have been diagnosed with Prader-Willi Syndrome (PWS), confirmed through genetic testing - People who score 12 or above on the Epworth Sleepiness Scale (ESS), which is a standard questionnaire used to measure daytime sleepiness Who may not be able to join: - People who...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05939934 · University Hospital, Angers Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2026
🇫🇷 FR

Who might be able to join this trial: - People who are willing to use a Mandibular Advancement Device (MAD), which is a type of mouthguard worn during sleep to help keep the airway open - People whose initial sleep test showed more than 15 breathing interruptions per hour during sleep - People who experience excessive...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05953610 · University of California, Los Angeles Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 31 August 2028
🇺🇸 US

**Who might be able to join this trial:** - Adults aged 21 years or older - People diagnosed with moderate to severe obstructive sleep apnea, meaning their breathing stops or becomes disrupted 15 or more times per hour during sleep - People whose sleep apnea is mostly obstructive, with fewer than 5 central or mixed bre...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05958563 · University Hospital, Angers Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2028
🇫🇷 FR

**Who might be able to join this trial:** - People who are 40 years of age or older - People whose breathlessness is rated at grade 2 or higher on a standard 0–4 breathlessness scale, meaning at least some limitation to daily activities due to shortness of breath - People whose lung function tests show reduced airflow...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05963607 · VA Office of Research and Development Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2029
🇺🇸 US

**Who might be able to join this trial:** - People who are enrolled in VA (Veterans Affairs) healthcare - People of any gender aged 18 or older - People who have been diagnosed with long-term (at least 6 months) non-cancer muscle or joint pain, recorded at two or more medical appointments, and who rate their pain at 3...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05985811 · Salem Anaesthesia Pain Clinic Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇨🇦 CA

Who might be able to join this trial: - Adults who are living with chronic (long-term) pain - People who have a mood disorder alongside their chronic pain - People who also experience chronic insomnia (ongoing, persistent difficulty sleeping) - People who are already receiving regular ketamine injections as part of the...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05988385 · California Pacific Medical Center Research Institute Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2027
🇺🇸 US

Who might be able to join this trial: - People aged between 55 and 85 years old - People whose thinking and memory are considered normal, based on a cognitive screening test score of 29 or higher - People who have moderate to severe sleep apnea, confirmed by a sleep test taken within the past 12 months (or confirmed by...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06002022 · Fundación para la Investigación del Hospital Clínico de Valencia Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 28 July 2025
🇪🇸 ES

**Who might be able to join this trial:** - You must be willing and able to give written consent to take part before joining the trial, following local rules and regulations. - You have been diagnosed with stage I, II, or III breast cancer (confirmed by a tissue sample/biopsy) and are currently receiving hormone-based...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06002581 · Shanghai General Hospital, Shanghai Jiao Tong University School of Med... Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 28 July 2026
🇨🇳 CN

Who might be able to join this trial: - People diagnosed with Parkinson's disease that meets recognised medical diagnostic standards (either a confirmed or probable diagnosis). - People of Chinese Han heritage (across three generations), aged between 50 and 80 years old, of any gender. - People whose Parkinson's diseas...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06008626 · Cryosa, Inc. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2026
🇺🇸 US

**Who might be able to join this trial:** - People between 22 and 70 years of age - People who are unable to use, refuse to use, or cannot tolerate CPAP or a mouth device (mandibular advancement device) for sleep apnea — or, if using one, are doing so for less than 4 hours a night on fewer than 5 days a week - People...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06028113 · Children's Hospital Medical Center, Cincinnati Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 30 November 2025
🇺🇸 US

Who might be able to join this trial: - The baby was born weighing 2,500 grams (about 5.5 pounds) or more - The baby was born between 37 and 42 weeks of pregnancy (considered full-term) - The caregiver speaks English - The baby receives primary care at the paediatric clinic running this trial - The family comes from a...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06030349 · Children's Health Ireland Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 28 November 2027
🇮🇪 IE🇬🇧 GB

Who might be able to join this trial: - People who have a confirmed diagnosis of Down Syndrome and whose doctor has decided they need to start non-invasive breathing support (such as a CPAP or BiPAP mask-based device). - People whose sleep study results show more than 2 breathing interruptions per hour, or more than 1...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06032377 · Centre de Recherche de l'Institut Universitaire de Geriatrie de Montre... Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2026
🇨🇦 CA

**Who might be able to join this trial:** - You are 60 years of age or older when you sign up - You have sleep problems, based on a sleep questionnaire score of 16 or below, and/or you meet certain standard criteria for insomnia based on your symptoms - You have noticed problems with your memory or thinking in everyda...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06032715 · University Hospital, Akershus Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2024
🇳🇴 NO

Who might be able to join this trial: - People who report using Z-hypnotics (a type of sleeping pill, such as zopiclone or zolpidem) more than 4 days per week for more than 4 weeks Who may not be able to join: - People who have been diagnosed with dementia - People who have been diagnosed with psychosis - People who h...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06044935 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDD... Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 January 2027
🇺🇸 US

Who might be able to join this trial: - Adult males between 18 and 65 years old, or pre-menopausal adult females between 18 and 50 years old — including those with a specific inherited form of diabetes called MODY2 - People whose weight has been stable (not changing by more than 5%) over the past 6 months - People with...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06047353 · University of Miami Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2027
🇺🇸 US

Who might be able to join this trial: - You are 18 years of age or older - You have been diagnosed with moderate-to-severe obstructive sleep apnea (OSA), which means you stop breathing frequently during sleep - You are able to attend the required study visits and sessions - You have reliable access to a phone Who may...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06047496 · University of California, San Diego Early Phase 1 · 1 country Recruiting
Recruiting Early Phase 1 Est. completion 1 July 2027
🇺🇸 US

**Who might be able to join this trial:** - You are between 18 and 70 years old - You are willing to sign a consent form and follow all study requirements for the full duration of the trial - You own a smartphone (iPhone or Android) - You currently eat across a window of 12 hours or more per day, and are able to log yo...

Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.
NCT06052397 · Massachusetts General Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2026
🇺🇸 US

Who might be able to join this trial: - People who are 70 years of age or older - People who are scheduled to have a major bone or joint surgery - People whose recovery in hospital after surgery is expected to last more than 24 hours Who may not be able to join: - People who have a cognitive (thinking or memory) condi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06061562 · University Hospital, Grenoble Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇫🇷 FR

Who might be able to join this trial: - People who have Down syndrome, meaning their cells carry an extra copy (all or part) of chromosome 21 Who may not be able to join: - People whose heart electrical activity test (ECG) shows abnormal results - People who have heart failure or cardiovascular (heart and blood vessel...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06062953 · Lone Baandrup Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 28 February 2029
🇩🇰 DK

Who might be able to join this trial: - People aged 16 to 64 years old - People who have been diagnosed with a current or past mental or behavioural disorder that falls within specific recognised categories (confirm with trial site for the full list of qualifying diagnoses) - People diagnosed with autism spectrum disor...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06070194 · Pennington Biomedical Research Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2028
🇺🇸 US

**Who might be able to join this trial:** - People aged between 18 and 45 years old - People with a body mass index (a measure of body weight relative to height) between 25 and 35 - People who typically sleep 6.5 hours or less per night - People who typically have an eating window (the time from their first to last me...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06088810 · Duke University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2026
🇺🇸 US

Who might be able to join this trial: **For people living with dementia:** - People aged 60 or older - People who have been diagnosed with dementia by a doctor, or who report memory problems and score above a certain level on a standard memory assessment tool - People who score above 10 on a standard questionnaire tha...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06093633 · Itamar-Medical, Israel Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 1 October 2025
🇮🇱 IL🇺🇸 US

Who might be able to join this trial: - People between the ages of 12 and 99 - People who are able to read, understand, and sign a consent form, or children under 18 whose parents can sign on their behalf, and who have been referred for an overnight sleep study at a clinical sleep laboratory - People who are suspected...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06103630 · National Cheng-Kung University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇹🇼 TW

Who might be able to join this trial: - People who have been diagnosed with obstructive sleep apnea (OSA) - People aged 21 years or older - People who are currently wearing a Mandibular Advancement Device (a dental mouthpiece used to treat sleep apnea), adjusted to at least 50% of the maximum setting possible for that...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06104774 · China Medical University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇹🇼 TW

**Who might be able to join this trial:** - You are scheduled to have a type of lung surgery performed through small cuts in the chest (such as removal of part or all of a lung lobe) - Your overall health has been rated by a doctor as either fully healthy or having only mild health conditions that do not greatly limit...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06107517 · National University Hospital, Singapore Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2026
🇸🇬 SG

Who might be able to join this trial: - People who have been assessed by their doctors as medically suitable for planned (non-emergency) heart bypass surgery (CABG) - People aged 21 years or older - People who speak English or Mandarin - People who are able to give their own consent to participate Who may not be able...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06108830 · Tianjin Medical University General Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 November 2024
🇨🇳 CN

**Who might be able to join this trial:** - People between 20 and 65 years of age - People with an ASA physical status classification of Grade I, II, or III (a rating used by anaesthetists to describe overall health before surgery — confirm with trial site) - People who are scheduled for a planned, non-emergency surger...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06109363 · Chinese University of Hong Kong Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 22 October 2026
Hong Kong

Who might be able to join this trial: - Adults of Chinese background between 18 and 70 years old - People whose insomnia symptoms score 10 or higher on a standard insomnia rating scale called the Insomnia Severity Index Who may not be able to join: - People who have a psychotic disorder, such as bipolar disorder or sc...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06115018 · Yi-Ju, Lai Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇹🇼 TW

Who might be able to join this trial: - People who have been diagnosed with mild to severe obstructive sleep apnea Who may not be able to join: - People who have chronic sinus inflammation with nasal polyps (growths inside the nose) - People who have enlarged adenoids (tissue at the back of the nasal passage) - People...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06117579 · Centre Hospitalier Régional d'Orléans Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 25 October 2026
🇫🇷 FR

Who might be able to join this trial: - Adults aged 18 years or older - People who have been diagnosed with obstructive sleep apnea (a condition where breathing repeatedly stops during sleep) with a severity score of 5 or more on a standard sleep test, and whose condition requires CPAP treatment (a breathing machine us...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06129942 · Second Affiliated Hospital of Soochow University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 16 May 2026
🇨🇳 CN

**Who might be able to join this trial:** - You have been diagnosed with Parkinson's disease according to standard medical guidelines, with symptoms at a moderate stage (not too mild and not too severe, known as Hoehn and Yahr stages 2–3). - You have been on a stable Parkinson's medication routine for at least one mont...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06132477 · University of Missouri-Columbia Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 July 2028
🇺🇸 US

**Who might be able to join this trial:** - People who are over 18 years of age - People who are receiving care from a surgeon at MU Health Care - People who are having weight loss surgery through the Weight Management and Metabolic Center - People whose body mass index (a measure of body weight relative to height) fa...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06150352 · The University of Hong Kong Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2026
Hong Kong

**Who might be able to join this trial:** - You are between 50 and 80 years old - You have been diagnosed with mild cognitive impairment (early-stage memory or thinking difficulties) based on a specific set of medical guidelines known as Peterson's criteria - You have noticed problems with your memory or thinking yours...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06155916 · Helsinki University Central Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇫🇮 FI

Who might be able to join this trial: - You have had painful nerve damage (a condition affecting the nerves outside the brain and spinal cord) that has lasted for more than 3 months - Your pain has been moderate to severe, meaning you would rate it at least 4 out of 10 on a pain scale over the past week Who may not be...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06156293 · Chinese University of Hong Kong Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇨🇳 CN

Who might be able to join this trial: - Adults of Chinese background between 18 and 70 years of age. - People whose score on the Insomnia Severity Index is less than 10, meaning their sleep difficulties are mild or minimal (confirm with trial site). Who may not be able to join: - People who have a psychotic disorder s...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06156306 · Chinese University of Hong Kong Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 December 2025
Hong Kong

**Who might be able to join this trial:** - Chinese young people between 15 and 24 years old - People whose insomnia symptoms score 9 or above on a standard insomnia measurement scale (the Insomnia Severity Index) - People whose anxiety symptoms score 10 or above on a standard anxiety measurement scale (the General Anx...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06157840 · Medical University of South Carolina Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 September 2026
🇺🇸 US

Who might be able to join this trial: - People who have not experienced withdrawal symptoms in the past 2 weeks - People who are currently stabilised on buprenorphine, either having started it within the past 3 months or having had their dose adjusted within the past 3 months (for example, reducing the dose with a goal...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06189755 · University of Pennsylvania Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 1 November 2027
Iceland🇺🇸 US

Who might be able to join this trial: **If you have sleep apnea (Cases):** - You are between 18 and 75 years old - You have been diagnosed with moderate to severe sleep apnea (meaning your breathing stops or becomes shallow at least 15 times per hour during sleep) - You are willing to use a PAP machine (a breathing de...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06192615 · Massachusetts General Hospital Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 31 October 2027
🇺🇸 US

**Who might be able to join this trial:** - You are 60 years of age or older - You are scheduled to have heart surgery that involves a heart-lung bypass machine - You are expected to be admitted to the intensive care unit (ICU) after your surgery **Who may not be able to join:** - You have a known allergy or sensitivi...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06194344 · The University of Texas Health Science Center, Houston Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇺🇸 US

Who might be able to join this trial: - People who have a primary diagnosis of a schizophrenia-related condition or a mood disorder that includes psychotic features, as confirmed by their treatment team or medical records. - People who have been assessed by a licensed psychologist or attending psychiatrist as being abl...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06198699 · National Cheng Kung University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇹🇼 TW

**For people with dementia:** Who might be able to join this trial: - People who have been diagnosed with dementia - People who are 50 years of age or older - People who have enough cognitive ability to answer survey questionnaires - People who are able to communicate in Mandarin or Taiwanese Who may not be able to j...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06222255 · Seoul National University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇰🇷 KR

**Who might be able to join this trial:** - Adults aged 19 years or older. - People who have had surgery to remove part of the rectum (the lower part of the large bowel) due to rectal cancer, where the cancer was within 15cm of the opening of the back passage. - People who are at least 24 months (2 years) past their su...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06226077 · University of Minnesota Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 November 2026
🇺🇸 US

Who might be able to join this trial: - People who are not currently meeting the recommended levels of physical activity - People between the ages of 21 and 75 years old - People with a body mass index (a measure of body weight relative to height) of 25.0 or above - People who typically sleep 6 hours or less per night...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06227572 · Washington State University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇺🇸 US

Who might be able to join this trial: - People aged 50 years or older - People who identify as American Indian or Alaskan Native - People who have been diagnosed with obstructive sleep apnea (a condition where breathing repeatedly stops and starts during sleep) - People who have been prescribed PAP therapy (a breathing...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06237842 · SleepUp Tecnologia em Saúde Ltda Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇧🇷 BR

Who might be able to join this trial: - People of any gender - Children and teenagers between 3 and 18 years old - People who live in the city of São Paulo, Brazil - People who are scheduled to have a sleep study (called a polysomnography) at the Sleep Laboratory of the Children's Institute at Hospital das Clínicas, Un...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06240325 · University of Pittsburgh Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2026
🇺🇸 US

**Who might be able to join this trial:** **For young people:** - You are willing to take part and have permission from a parent or guardian - You are between 12 and 18 years old - You are currently a patient at Kids Plus Pediatrics - You are currently experiencing depression - You sleep less than 7 hours on school ni...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06250725 · Emory University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2026
🇺🇸 US

**Who might be able to join this trial:** **For people living with cognitive impairment:** - People who have been diagnosed with Alzheimer's Disease or a related form of dementia, or whose caregiver has reported that they likely have some level of memory or thinking problems - People who score between 12 and 24 on a s...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06251258 · University Hospital, Angers Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2027
🇫🇷 FR

Who might be able to join this trial: - People aged between 18 and 65 years old - People who have given signed consent to take part in the study - People who are covered by a social security or health insurance scheme - People joining the insomnia group must have a known diagnosis of insomnia and be receiving treatment...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06252571 · University Hospital, Strasbourg, France Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 7 September 2027
🇫🇷 FR

**Who might be able to join this trial:** - People who are aged between 18 and 40 years old at the time of signing the consent form - People who have been diagnosed with Idiopathic Hypersomnia (a condition causing excessive sleepiness) at a specialist sleep disorder centre, following recognised international diagnosti...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06258837 · Oregon Health and Science University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2028
🇺🇸 US

**Who might be able to join this trial:** - The child has been diagnosed with moderate to severe sleep apnea (a condition where breathing repeatedly stops during sleep), confirmed by a sleep study showing a certain level of breathing interruptions. - The child is between 2 and 17 years old. - The child has small tonsi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06266611 · University of Colorado, Boulder Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 30 May 2028
🇺🇸 US

**Who might be able to join this trial:** - People who are able to give informed consent to participate - People who are 25 years of age or older at the first study visit - People who have been diagnosed with any type of solid tumour and who are currently receiving, or have received in the past 18 months, treatment ai...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06270290 · Guy's and St Thomas' NHS Foundation Trust Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2026
🇬🇧 GB

**Who might be able to join this trial:** *RBD Group:* - People who are patients at the Sleep Disorders Centre at Guy's and St Thomas' NHS Foundation Trust and have been diagnosed with REM Sleep Behaviour Disorder (a sleep condition where people act out their dreams). - People who are 50 years of age or older. *Contr...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06274034 · Mayo Clinic Early Phase 1 · 1 country Recruiting
Recruiting Early Phase 1 Est. completion 31 January 2029
🇺🇸 US

**Who might be able to join this trial:** - You are between 18 and 80 years old - You were first diagnosed with stage 1 to 4 breast cancer within the last 10 years - You are currently experiencing both anxiety and sleep problems (insomnia), each rated above 3 out of 10 in terms of how much they affect you - If you take...

Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.
NCT06274528 · University of Minnesota Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 31 March 2030
🇺🇸 US

**Who might be able to join this trial:** - You can be male or female, of any race or ethnicity. - You must be 65 years of age or older and able to sign a consent form yourself. - You must show no signs of memory or thinking problems based on a standard assessment called the Clinical Dementia Rating (confirm with trial...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06278259 · Cairo University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 28 November 2025
🇪🇬 EG

**Who might be able to join this trial:** - People who have been diagnosed with a stroke, confirmed by a CT scan or MRI. - People aged 65 years or older (both men and women). - People whose basic body functions, such as heart rate and blood pressure, are currently stable. **Who may not be able to join:** - People who...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06281145 · Comenius University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 March 2027
🇸🇰 SK

Who might be able to join this trial: - You must be 18 years of age or older. - You have been diagnosed with breast cancer and are about to start treatment before surgery, or you have colon cancer and have had surgery to remove it and now need additional treatment — confirmed by a laboratory test. - Your kidneys are wo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06281756 · Milton S. Hershey Medical Center Early Phase 1 · 2 countries Recruiting
Recruiting Early Phase 1 Est. completion 30 November 2027
🇨🇦 CA🇺🇸 US

**Who might be able to join this trial:** - People aged 18 or older - People who can read and communicate effectively in English (at US sites), or in English or French (at the Canadian site) - People who meet the clinical criteria for chronic insomnia - People with a Body Mass Index (BMI) of 18.5 or higher **Who may n...

Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.
NCT06283095 · ET Zarief Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2025
🇪🇬 EG

**Who might be able to join this trial:** - You must be an adult (18 years or older) - Your body weight relative to your height (BMI) must be less than 30 kg/m² - You have been diagnosed with mild to moderate sleep apnea (a condition where breathing repeatedly stops during sleep) - A special sleep test using a camera a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06286189 · Brigham and Women's Hospital Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 January 2026
🇺🇸 US

**Who might be able to join this trial:** - People who have moderate-to-severe obstructive sleep apnea, meaning their sleep study showed 15 or more breathing interruptions per hour **Who may not be able to join:** - People who have a serious disease affecting a major organ (such as the heart, lungs, or kidneys) that w...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06290063 · University of Colorado, Boulder Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 31 August 2028
🇺🇸 US

Who might be able to join this trial: - People who are at least 60 years old - People who are able to give informed consent (formally agree to take part in the study) - People who have tried a cannabis product at least once in the past with no negative effects - People who have not been using cannabis products regularl...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06306092 · Kristianstad University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2028
🇸🇪 SE

Who might be able to join this trial: - You are a student attending a high school or upper secondary school in Sweden. Who may not be able to join: - There are no specific exclusion criteria listed for this trial (confirm with trial site). Important: Always verify eligibility with the trial site directly before apply...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06312956 · Istituto Auxologico Italiano Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇮🇹 IT

Who might be able to join this trial: - People who have been diagnosed with obstructive sleep apnea syndrome, confirmed by a test showing more than 5 breathing interruptions per hour during sleep - People who are right-handed Who may not be able to join: - People who have previously used breathing therapy machines (su...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06319482 · NovaResp Technologies Inc Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 16 June 2025
🇨🇦 CA

Who might be able to join this trial: - People who have recently been diagnosed with moderate or severe sleep apnea, meaning their breathing stops or becomes shallow more than 15 times per hour during sleep. - People who are between 18 and 70 years old. - People who do not have a history of severe heart or brain/nervou...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06331819 · Jordan Collaborating Cardiology Group Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2026
🇯🇴 JO

Who might be able to join this trial: - People within the required age range (confirm age limits with trial site) who agree to take part and sign a consent form. Who may not be able to join: - People who have already been diagnosed with obstructive sleep apnea (a condition where breathing repeatedly stops and starts d...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06332404 · University Hospital, Antwerp Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2034
🇧🇪 BE

Who might be able to join this trial: - People who are at least 18 years old at the time of receiving the device implant - People who have moderate to severe obstructive sleep apnoea, meaning their breathing interruptions during sleep fall within a specific measured range (between 15 and 65 events per hour) - People wh...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06335784 · University Hospital, Geneva Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 May 2027
🇨🇭 CH

Who might be able to join this trial: - People aged between 18 and 45 years old - People who have been diagnosed with insomnia disorder according to a standard sleep disorder classification system (ICSD-3) - People whose insomnia severity score is above 10 on a standard questionnaire called the Insomnia Severity Index...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06337149 · Assistance Publique - Hôpitaux de Paris Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2025
🇫🇷 FR

"Who might be able to join this trial: - Children aged 6 to 16 years old who have been diagnosed with CCHS (also known as Ondine Syndrome, a rare condition that affects automatic breathing) - Children with an IQ score above 70 - Children who speak French - Children whose both parents have signed a consent form agreeing...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06341179 · University of Copenhagen Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇩🇰 DK

**Who might be able to join this trial:** - Children who are between 6 and 12 years old (inclusive). - Children whose body weight is above average for their age and sex, based on World Health Organization reference standards. - Children who typically sleep 9 hours or less per night, based on a sleep diary filled in by...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06351839 · University of Tromso Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇳🇴 NO

Who might be able to join this trial: - People who have been examined at the University Hospital of Northern Norway (UNN) and have been given a diagnosis of long-term, non-cancer-related pain according to standard international diagnosis codes (ICD-10) - People who also have ongoing sleep problems (insomnia) alongside...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06358495 · University of Calgary Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2025
🇨🇦 CA

Who might be able to join this trial: - People aged between 12 and 18 years old. - People who have at least one parent with a history of depression or anxiety disorders, but who do not have a significant personal history of these types of conditions themselves. - People who score 10 out of 25 or higher on a standard sl...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06359808 · Xijing Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2026
🇨🇳 CN

**Who might be able to join this trial:** - People who have been diagnosed with ulcerative colitis based on specific Chinese medical guidelines (Beijing, 2018) - People who have complete medical records and are willing to sign a consent form **Who may not be able to join:** - People who have a history of mental illnes...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06363981 · Jakub Antczak Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇵🇱 PL

Who might be able to join this trial: - People who have been diagnosed with a moderate or severe depressive episode (without psychotic symptoms) at the time of joining the trial, based on standard international diagnostic guidelines. - People whose depression severity scores between 20 and 35 points on a standard clini...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06367400 · Uppsala University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2024
🇸🇪 SE

Who might be able to join this trial: - Children who have been referred to an ear, nose, and throat (ENT) clinic because of symptoms related to breathing problems during sleep - Children who are between 18 months and 15 years old - Children (and/or their parents or guardians) who have a good understanding of the Swedis...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06371352 · Jakub Antczak Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇵🇱 PL

Who might be able to join this trial: - People who are currently experiencing a moderate or severe depressive episode without psychotic symptoms, as diagnosed using international medical guidelines (ICD-10) - People who have a diagnosis of recurring major depression or bipolar disorder (specific diagnostic codes: F33.1...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06375447 · Xuanwu Hospital, Beijing Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 October 2025
🇨🇳 CN

Who might be able to join this trial: - People who have a complaint of insomnia (trouble sleeping) - People aged between 18 and 75 years old - People who are able to independently fill out questionnaires or rating scales - People who agree to sign a consent form and commit to attending follow-up visits as part of the s...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06376760 · Beijing Tiantan Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 March 2027
🇨🇳 CN

**Who might be able to join this trial:** **For people with insomnia:** - Adults aged 18 to 64 years - People rated as generally healthy or with only mild health conditions (ASA physical status I–II) (confirm with trial site) - People with a body mass index (BMI) between 15 and 30 - People already scheduled to have a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06378515 · University of Valencia Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2025
🇪🇸 ES

**Who might be able to join this trial:** - You are currently enrolled in a bachelor's degree program at one of the universities taking part in this study. - You are willing to give your consent to participate and have been fully informed about what the study involves. **Who may not be able to join:** - You are under...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06379074 · University of Rome G. Marconi Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 6 August 2026
🇮🇹 IT

Who might be able to join this trial: - People who are 18 years of age or older - People who have a good understanding of the Italian language - People who plan to continue with their pregnancy - People whose BMI (a measure of body weight relative to height) falls between 18 and 30, meaning they are neither underweight...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06380491 · Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 22 December 2027
🇲🇽 MX

Who might be able to join this trial: - People who have been diagnosed with Obstructive Sleep Apnea (a condition where breathing repeatedly stops during sleep) confirmed by an overnight sleep study - People whose blood pressure does not drop as expected during sleep, as measured by a device worn to monitor blood pressu...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06384742 · Oregon State University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2027
🇺🇸 US

Who might be able to join this trial: - People who are between 18 and 65 years old, of any gender - People who are currently working as a nurse or nursing staff member (such as a Certified Nursing Assistant) in the United States - People who currently work night shifts or rotating shifts that include at least 2 nights...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06385054 · Lallemand Health Solutions Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 February 2026
🇫🇷 FR

Who might be able to join this trial: - The infant must be healthy, either male or female. - The infant must be 8 weeks old or younger. - The infant must have been diagnosed with infantile colic according to specific medical guidelines (called Rome IV criteria), meaning the baby cries or fusses for 3 or more hours per...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06385106 · First Affiliated Hospital of Zhejiang University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇨🇳 CN

**Who might be able to join this trial:** - You have been diagnosed with a type of memory problem consistent with Alzheimer's disease (AD), confirmed by memory testing and either a spinal fluid test or a brain scan showing signs of AD. - You are between 55 and 80 years old. - You do not have significant problems with...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06386497 · Insel Gruppe AG, University Hospital Bern Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇨🇭 CH

**Who might be able to join this trial:** - People who have signed an informed consent form agreeing to take part in the study - People who have been diagnosed with Parkinson's disease according to recognised medical diagnostic guidelines - People who have poor sleep quality, as shown by a score of more than 5 on a sta...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06396520 · Danish Research Centre for Magnetic Resonance Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇩🇰 DK

**Who might be able to join this trial:** *For babies identified as high-risk (detected shortly after birth):* - Babies born before 32 weeks of pregnancy - Babies born weighing less than 1,500 grams (about 3.3 pounds) - Babies diagnosed with a moderate to severe brain injury, such as bleeding in the brain, damage to b...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06397365 · Solelhac Geoffroy Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 February 2027
🇨🇭 CH

Who might be able to join this trial: - People who are 18 years of age or older - People for whom long-term CPAP therapy has been recommended to treat a sleep-related breathing condition - People who have not been able to tolerate CPAP and are using it for less than 3 hours per night on average, as assessed at a follow...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06399939 · University of Massachusetts, Amherst Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 January 2028
🇺🇸 US

**Who might be able to join this trial:** - Your baby is 9 months old at the time of enrollment - Your baby was born at a normal weight (between 5.5 and 10 lbs) and after a typical length pregnancy (between 36 and 41 weeks) - You are able and willing to come back for follow-up visits at 3 and 6 months from enrollment (...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06407518 · Sixth Affiliated Hospital, Sun Yat-sen University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2025
🇨🇳 CN

**Who might be able to join this trial:** - People who have given their voluntary written agreement to participate - Native Chinese speakers - Adults aged 18 to 60 years old, of any gender - People with a body mass index (a height-to-weight measurement) between 18 and 30 - People whose general health has been assessed...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06411561 · University of Washington Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 May 2027
🇺🇸 US

Who might be able to join this trial: - People who are 60 years of age or older - People who are currently admitted to University of Washington Medical Center or Harborview Medical Center - People who have spent more than 24 hours in an intensive care unit (ICU) - People who have recovered from critical care and moved...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06422741 · Fundació Eurecat Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 February 2026
🇪🇸 ES

**Who might be able to join this trial:** - Adults aged 18 years or older, of any gender. - People who have worked a rotating night shift schedule for at least one year before the study begins, meaning at least 5 night shifts per month alternating with day and/or afternoon shifts. - People who do not plan to change th...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06423118 · Sunnybrook Health Sciences Centre Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2034
🇨🇦 CA

**Who might be able to join this trial:** - People who have a good enough understanding of English to give informed consent - People who are mentally able to give their own consent to participate - People aged between 55 and 85 years old, of any gender - People who have completed at least 8 years of education - People...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06430086 · Columbia University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇺🇸 US

**Who might be able to join this trial:** - Men and post-menopausal women (the trial is looking for equal numbers of each, specifically 12 men and 12 post-menopausal women) - People with a body mass index (BMI) in either the normal range (18.5–24.9) or the overweight range (25–29.9) - People who self-report poor sleep...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06430333 · Henry Ford Health System Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 29 February 2028
🇺🇸 US

**Who might be able to join this trial:** - People who are pregnant with one baby, between 14 and 31 weeks along at the time of screening - People who have been diagnosed with Insomnia Disorder according to standard psychiatric guidelines, lasting at least one month - People whose insomnia scores at least 11 on a stand...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06430957 · Kırıkkale University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2026
Turkey (Türkiye)

Who might be able to join this trial: - Adults between 18 and 80 years old who are attending an anesthesia clinic for a dental procedure planned to be carried out under general anesthesia - People who have not previously been diagnosed with obstructive sleep apnea (a condition where breathing repeatedly stops and start...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06434571 · University of Kansas Medical Center Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 31 July 2028
🇺🇸 US

**Who might be able to join this trial:** - People between 18 and 65 years old - People who have been diagnosed with relapsing-remitting or secondary progressive MS, confirmed by their neurologist - People with mild-to-moderate disability, scoring 6 or below on a scale called the Patient Determined Disability Steps (P...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06441864 · University of Utah Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇺🇸 US

Who might be able to join this trial: - People who have been diagnosed with RBD (a sleep condition where people act out their dreams) either on its own or linked to a brain/nerve disease - People aged 18 or older - People who can speak, read, and write in English - People who live in the United States - People who expe...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06453018 · Chinese University of Hong Kong Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
Hong Kong

**Who might be able to join this trial:** - Your child is between 6 and 17 years old - Your child has been diagnosed with positional obstructive sleep apnea (a type of sleep apnea that is worse when sleeping on their back) based on an overnight sleep study, with specific test results meeting set thresholds (confirm wit...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06455592 · University Hospital, Clermont-Ferrand Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2027
🇫🇷 FR

Who might be able to join this trial: - Children aged 5 to 16 who have a blood cancer and are currently receiving treatment for it - Children whose parents have been told about the study and have agreed to take part - Children who are enrolled in the Social Security system Who may not be able to join: - Children who a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06463561 · Hospital Universitario La Paz Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 30 July 2027
🇪🇸 ES

**Who might be able to join this trial:** - People aged between 35 and 80 years old - People who have been diagnosed with dyslipidemia (a condition where blood fat levels such as cholesterol or triglycerides are abnormal), either through a previous diagnosis, current medication for it, or a recent blood test showing: t...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06464367 · Yale University Early Phase 1 · 1 country Recruiting
Recruiting Early Phase 1 Est. completion 31 December 2027
🇺🇸 US

Who might be able to join this trial: - People aged 21 to 70 years old (inclusive) - People who have been diagnosed with migraine disease according to standard medical diagnostic guidelines (ICHD-3 criteria), or people who are generally healthy and do not have migraine (as a comparison group) Who may not be able to jo...

Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.
NCT06467461 · University of Minnesota Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2027
🇺🇸 US

Who might be able to join this trial: **For people with serotonergic REM sleep behaviour disorder (5-HT RBD):** - People who have been diagnosed with REM sleep behaviour disorder (RBD), confirmed by a sleep study, and who have a history of acting out their dreams (or this was captured on video during the sleep study)....

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06468618 · Dana-Farber Cancer Institute Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇺🇸 US

Who might be able to join this trial: - Children and teenagers between 9 and 17 years old. - Patients who are scheduled to receive a stem cell transplant at Boston Children's Hospital. - Both the child and their main caregiver (such as a parent or guardian) speak English. Who may not be able to join: - Patients whose...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06471374 · University of Colorado, Boulder Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2028
🇺🇸 US

Who might be able to join this trial: - People who have been diagnosed with Delayed Sleep Wake Phase Disorder (a condition where a person's sleep schedule is shifted significantly later than normal). - People who currently live at an altitude equal to or higher than Denver, Colorado. - People whose Body Mass Index (BMI...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06471751 · Centre Hospitalier Universitaire de Saint Etienne Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2026
🇫🇷 FR

**Who might be able to join this trial:** - People diagnosed with moderate sleep apnea, meaning their breathing interruption score (called an AHI) is between 15 and 30 per hour - People with a Body Mass Index (BMI) under 35 - People who are covered by a social security or health insurance scheme - People who have agree...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06474390 · PranaQ Pte. Ltd. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 May 2025
🇹🇼 TW

Who might be able to join this trial: - People aged 20 or older who have been scheduled for an overnight sleep study (called a PSG) at Duke University Hospital - People who are able to understand the study information and sign a consent form before joining - People who are willing to participate, with the freedom to le...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06477952 · VA Office of Research and Development Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 31 December 2026
🇺🇸 US

**Who might be able to join this trial:** - Adults between 18 and 65 years old - People who have been diagnosed with moderate to moderately-severe sleep apnea, meaning their breathing stops or becomes shallow between 15 and 50 times per hour during a sleep study **Who may not be able to join:** - People who have been...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06480305 · Riphah International University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 28 February 2025
🇵🇰 PK

Who might be able to join this trial: - People who are generally healthy - People who do not have conditions affecting the heart, blood vessels, nervous system, lungs, liver, or kidneys - People who do not have any known skin allergies Who may not be able to join: - People who have been diagnosed with a heart, liver,...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06482814 · Mayo Clinic Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2029
🇺🇸 US

**Who might be able to join this trial:** - Adults between 18 and 35 years old - People who are generally healthy, with no significant physical or mental health conditions (as decided by the study doctors) - Non-smokers - People who are not pregnant - People who normally sleep 7–9 hours per night and do not regularly t...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06484075 · National Institute on Alcohol Abuse and Alcoholism (NIAAA) Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 31 December 2028
🇺🇸 US

**Who might be able to join this trial:** **For all participants:** - People aged 18 to 75 years old, of any gender - People who are willing to follow all study procedures and be available for the full duration of the study - People who are able to understand and are willing to sign a written consent form **For parti...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06496282 · Phramongkutklao College of Medicine and Hospital Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 31 May 2026
🇹🇭 TH

**Who might be able to join this trial:** - People between 20 and 60 years old - People who have been working rotating shift schedules for at least 3 months and will continue doing so until the study ends - People who have sleep problems, such as sleeping less than 6 hours total or not being able to sleep effectively,...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06497894 · Insel Gruppe AG, University Hospital Bern Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 July 2026
🇨🇭 CH

**Who might be able to join this trial:** - Women who are in the late stage of the menopausal transition, as defined by a specific set of reproductive aging guidelines called STRAW+10 - People who score above 5 on a standard sleep quality questionnaire called the Pittsburgh Sleep Quality Index, which suggests poor sle...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06498128 · Idorsia Pharmaceuticals Ltd. Not Applicable · 7 countries Recruiting
Recruiting Not Applicable Est. completion 1 March 2033
🇨🇦 CA🇫🇷 FR🇩🇪 DE🇮🇹 IT🇪🇸 ES🇬🇧 GB🇺🇸 US

Who might be able to join this trial: **For ongoing pregnancies:** - People who had been diagnosed with insomnia before becoming pregnant - People whose pregnancy is still ongoing and the outcome (such as miscarriage or live birth) is not yet known - People who took a sleep medication called QUVIVIQ at any point durin...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06499311 · Cairo University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2024
🇪🇬 EG

**Who might be able to join this trial:** - Women between 45 and 55 years old. - Women with a body mass index (a measure of body weight relative to height) between 25 and 30 kilograms per meter squared (confirm with trial site, as the upper limit appears unclear in the source). - Postmenopausal women who experience mod...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06505109 · Erasmus Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2027
🇳🇱 NL

Who might be able to join this trial: - People who are taking part in a cardiac rehabilitation (heart recovery) program at one of the study centres, for any heart-related reason covered by Dutch medical guidelines - People aged 18 or older - People who are able to read and communicate in Dutch - People who are experien...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06507722 · Johns Hopkins University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2029
🇺🇸 US

Who might be able to join this trial: - People whose body weight falls in the "overweight" range for their age and sex, meaning their BMI is at or above the 85th percentile but below the 95th percentile according to standard growth charts (for people aged 21–23, the equivalent values for a 20-year-old are used) - Peopl...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06514482 · Hospital San Pedro de Logroño Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 May 2025
🇪🇸 ES

**Who might be able to join this trial:** - People attending a sleep clinic appointment to receive results from a sleep study for suspected obstructive sleep apnea (OSA) - People aged 18 years or older - People who have signed the informed consent form **Who may not be able to join:** - People who are unable to comple...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06519149 · Slow Wave, Inc. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 21 August 2025
🇺🇸 US

Who might be able to join this trial: - People who have signed and dated a consent form agreeing to take part - People who are unable to tolerate or have chosen not to use a CPAP or similar breathing pressure machine for sleep apnea - People who do not have very large tonsils (rated 3 or 4 out of 4 on a standard sizing...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06526585 · Stanford University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 August 2026
🇺🇸 US

Who might be able to join this trial: - People who are 18 years of age or older - People who have no medical reasons preventing them from having an MRI scan (for example, having certain types of metal implants in the body) Who may not be able to join: - People who are pregnant or who are planning to become pregnant du...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06527105 · Amrita Institute of Medical Sciences & Research Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2024
🇮🇳 IN

Who might be able to join this trial: - Adults aged 18 or older who are scheduled for a planned (non-emergency) heart surgery. Who may not be able to join: - People who are not willing to give their consent to take part in the trial. - People who are already taking sleep medications before their surgery. - People who...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06530043 · Riphah International University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 25 September 2024
🇵🇰 PK

**Who might be able to join this trial:** - People aged between 35 and 50 years old - People who have been diagnosed with COPD (a lung condition that makes it hard to breathe) at a moderate stage (classified as Stage 2 or Stage 3 according to a standard medical grading system called the GOLD criteria) - Both men and wo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06532773 · Duke University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2029
🇺🇸 US

Who might be able to join this trial: - Adults aged 18 or older, of any gender - People who have been recently diagnosed or re-diagnosed with acute myeloid leukemia, acute lymphoblastic leukemia, Non-Hodgkin's lymphoma, multiple myeloma, or myelodysplastic syndrome - People who are staying in hospital for at least 7 da...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06536764 · Riphah International University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2025
🇵🇰 PK

Who might be able to join this trial: - People who are pregnant and between 20 and 40 years old - People who are in their second or third trimester of pregnancy - People who have an uncomplicated pregnancy - People experiencing pregnancy-related lower back pain that scores more than 3 out of 10 on a standard pain scale...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06541886 · Indiana University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇺🇸 US

**Who might be able to join this trial:** - Adolescents aged 13 to 18 who are in middle school or high school and have been diagnosed with, or have experienced symptoms of, chronic insomnia disorder — either currently or within the past year — based on a self-reported screening checklist. - Adolescents who live in one...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06544941 · University of Colorado, Colorado Springs Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2027
🇺🇸 US

**Who might be able to join this trial:** - Pregnant women carrying a single baby who have a connection to the military - Between 18 and 45 years of age - Able to communicate during the screening process - Has access to a computer, smartphone, or tablet with an internet connection - Willing to use whichever bassinet is...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06550115 · Colorado State University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2028
🇺🇸 US

Who might be able to join this trial: - People aged between 18 and 65 years old - People who have been working night shifts for at least the past year - People who typically sleep between 5 and 9 hours within any 24-hour period - People with a Body Mass Index (BMI) between 20.0 and 35.0, whose weight has stayed within...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06553820 · Herlev and Gentofte Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇩🇰 DK

Who might be able to join this trial: - People aged 65 years or older - People who have been diagnosed with high blood pressure - People who can speak and read Danish - People who are able to give informed consent to participate - People who do not have other health conditions that would prevent them from taking part i...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06554496 · Nanjing Medical University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2025
🇨🇳 CN

**Who might be able to join this trial:** - Adults between 18 and 80 years of age - People who have been diagnosed with Obstructive Sleep Apnea Hypopnea Syndrome (a condition where breathing repeatedly stops or becomes shallow during sleep), with a specific severity score of 5 or more events per hour - People who are r...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06556693 · Zoll Medical Corporation Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2028
🇺🇸 US

Who might be able to join this trial: - People who have been diagnosed with severe sleep-disordered breathing (a condition where breathing is seriously disrupted during sleep) - People who are expected to be able to handle the procedures involved in the study - People who either do not have heart failure, or whose hear...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06559306 · Janssen Research & Development, LLC Phase 3 · 16 countries Recruiting
Recruiting Phase 3 Est. completion 30 December 2026
🇦🇷 AR🇧🇷 BR🇧🇬 BG🇨🇴 CO🇨🇿 CZ🇮🇹 IT🇲🇽 MX🇵🇱 PL +8 more

**Who might be able to join this trial:** - You have been diagnosed with major depressive disorder (a serious form of depression) without hallucinations or delusions, and your first episode of depression began before age 60 - Your current depression has not improved enough (less than 50% better, but at least some impr...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06559956 · University Hospital, Antwerp Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2028
🇧🇪 BE

Who might be able to join this trial: - People who have been diagnosed with obstructive sleep apnea (a condition where breathing stops and starts during sleep) and have had a specific implanted device called the Inspire system fitted to help treat it - People in Group 1: Those who have already had an overnight sleep st...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06564896 · National University of Malaysia Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇲🇾 MY

Who might be able to join this trial: - You must be 18 years old or older. - You must have been diagnosed with moderate to severe obstructive sleep apnea (a condition where breathing repeatedly stops during sleep), confirmed by a sleep study. - You must be able to understand and complete a questionnaire as part of the...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06566482 · Peking University First Hospital Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 September 2025
🇨🇳 CN

**Who might be able to join this trial:** - Adults aged 18 to 80 years old - People who have already been diagnosed with obstructive sleep apnea (OSA), or who score at moderate-to-high risk on a standard sleep apnea screening questionnaire called the STOP-Bang Questionnaire - People who are already scheduled to have k...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06568159 · University Hospital, Montpellier Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 14 February 2026
🇫🇷 FR

**Who might be able to join this trial:** - People who have coronary artery disease (a condition where the blood vessels supplying the heart are narrowed or blocked), with or without other health conditions such as smoking, diabetes, high blood pressure, high cholesterol, kidney problems, being overweight, anxiety, de...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06568367 · Axsome Therapeutics, Inc. Phase 3 · 2 countries Recruiting
Recruiting Phase 3 Est. completion 1 December 2026
🇨🇦 CA🇺🇸 US

Who might be able to join this trial: - People who have been diagnosed with Shift Work Disorder (a sleep condition caused by working non-traditional hours) according to recognised international diagnostic standards. - People who are willing and able to provide written consent before any study procedures begin. - People...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06570616 · University of Sao Paulo General Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇧🇷 BR

**Who might be able to join this trial:** - You have been diagnosed with moderate or severe obstructive sleep apnea (a sleep condition where breathing repeatedly stops and starts during sleep) - You currently use a CPAP machine (a device that helps you breathe during sleep) with a nasal mask - Your CPAP data from the l...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06570629 · University of Sao Paulo General Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇧🇷 BR

Who might be able to join this trial: - People who have been diagnosed with moderate or severe obstructive sleep apnea (a condition where breathing repeatedly stops during sleep) - People who are currently using a CPAP machine with a nasal mask to treat their sleep apnea - People whose CPAP data from the last 7 days sh...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06576310 · University Hospital, Toulouse Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 6 October 2027
🇫🇷 FR

Who might be able to join this trial: - People who have a full set of teeth, up to and including the second molars at the back of the mouth - People who have had a sleep study done (either a full overnight study in a clinic or a home-based breathing monitor test) - People who have been diagnosed with obstructive sleep...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06576830 · Duke University Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 31 December 2028
🇺🇸 US

Who might be able to join this trial: - Children aged 3 years old up to (but not including) 18 years old - Children scheduled for a planned tonsil removal, with or without adenoid removal - A parent or legal guardian has signed a consent form on the child's behalf - Children aged 12 and older must also sign a written c...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06578390 · Mitral Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 November 2025
🇫🇷 FR

**Who might be able to join this trial:** - People aged 18 or older, of any gender, with no upper age limit - People who have already been recommended to have an overnight sleep study (called a polysomnography) as part of their normal medical care, for any reason - People who typically sleep at least 6 hours per night,...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06579950 · Aditi Bunker Not Applicable · 5 countries Recruiting
Recruiting Not Applicable Est. completion 30 September 2027
Burkina Faso Fiji🇮🇳 IN🇲🇽 MX Niue

Who might be able to join this trial: - You must be a permanent resident of the household (meaning you live there full-time as your main home). Who may not be able to join: - Your roof has damage, cannot be safely accessed, or is unstable in a way that would prevent a cool roof coating from being applied. - You are un...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06580561 · University of Michigan Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 29 February 2028
🇺🇸 US

**Who might be able to join this trial:** - A doctor has diagnosed the person with knee osteoarthritis (this can be self-reported) - The person experiences ongoing knee pain that is at least moderate in intensity - The person has ongoing sleep problems consistent with insomnia, based on a specific sleep questionnaire...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06584513 · Insel Gruppe AG, University Hospital Bern Not Applicable · 6 countries Recruiting
Recruiting Not Applicable Est. completion 1 February 2026
🇧🇪 BE🇬🇷 GR🇳🇴 NO🇵🇱 PL🇪🇸 ES🇨🇭 CH

**Who might be able to join this trial:** - You are 65 years old or older - You have been taking sleep medications (such as benzodiazepines or similar sleeping pills) at least 3 times a week on average over the past 3 months, based on what you or a family member/carer reports - You are taking these sleep medications sp...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06586268 · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2025
🇳🇱 NL

**Who might be able to join this trial:** - People who have been diagnosed with obstructive sleep apnea (OSA), whether or not they are currently being treated for it, and who are scheduled for planned (non-emergency) surgery at the AUMC operating theatres with an expected hospital stay of at least 3 nights - People who...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06587256 · Johns Hopkins University Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 October 2030
🇺🇸 US

Who might be able to join this trial: - Adults with a Body Mass Index (BMI) of 35 or higher who report that they snore - People who have a bed partner able to answer questions about their snoring - People who have already had a sleep study showing either no sleep apnea, or only mild sleep apnea (meaning the sleep study...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06594627 · Indiana University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 11 July 2026
🇺🇸 US

**Who might be able to join this trial:** **For people who snore or have sleep apnea (OSA):** - People aged 50 years or older. - People who snore and/or have sleep apnea (OSA) in a way that affects their own sleep quality or their sleep partner's sleep quality. - People who are currently using a snoring or sleep apnea...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06609694 · Children's Hospital Medical Center, Cincinnati Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2027
🇺🇸 US

Who might be able to join this trial: - Children aged 5 to 17 years, with or without Down Syndrome, may be considered for this trial. - Children who have been diagnosed with obstructive sleep apnea (a condition where breathing is repeatedly blocked during sleep) with a severity score between 5 and 40 breathing disrupti...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06610955 · Ahi Evran University Education and Research Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2025
Turkey (Türkiye)

Who might be able to join this trial: - People who are female and between 18 and 45 years old - People with a body mass index (BMI) between 30 and 40, which is a measure of body weight relative to height - People whose excess weight is not caused by another medical condition (confirm with trial site) Who may not be ab...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06612853 · Schulthess Klinik Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2025
🇨🇭 CH

Who might be able to join this trial: - People of any gender are eligible - People who speak German or Italian - People who have been diagnosed with a spine condition - People aged 14 years or older - People who consider themselves to be cognitively intact (thinking and memory functioning normally, based on their own a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06618417 · Herlev and Gentofte Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 February 2027
🇩🇰 DK

Who might be able to join this trial: - People who have been diagnosed with a type of irregular heartbeat called atrial fibrillation (AF), either the kind that comes and goes or the kind that persists over time - People who own a compatible smartphone - People aged 18 years or older Who may not be able to join: - Peop...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06620601 · University Health Network, Toronto Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2024
🇨🇦 CA

Who might be able to join this trial: - People who are living in a shelter at the time they are recruited for the trial - People who are over 18 years old Who may not be able to join: - People who have an allergy to medical tape (this applies to the diagnosis part of the study) - People who need major dental work or w...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06627504 · University of Colorado, Denver Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 May 2029
🇺🇸 US

Who might be able to join this trial: - High school students between the ages of 14 and 19 years old - People who have been diagnosed with Type 1 diabetes for at least one year - People who use an insulin pump or a similar automated device to manage their insulin - People who typically sleep 7 hours or less per night o...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06628986 · Aysegul Kilicli Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 October 2025
Turkey (Türkiye)

Who might be able to join this trial: - People who are between 19 and 35 years old - People who have given birth by caesarean section (a surgical birth) - People who are having their first baby - People who are breastfeeding Who may not be able to join: - People who do not wish to take part in the research Important:...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06629207 · Insel Gruppe AG, University Hospital Bern Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2026
🇨🇭 CH

Who might be able to join this trial: - People who have been diagnosed with a sleep condition called isolated REM Sleep Behaviour Disorder (iRBD) by a specialist in movement disorders, confirmed using recognised international sleep disorder guidelines - People who are able and willing to give written consent to take pa...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06631742 · Eastern Switzerland University of Applied Sciences Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 January 2027
🇨🇭 CH

Who might be able to join this trial: - People who have been diagnosed with a neurocognitive disorder (such as dementia) caused by Alzheimer's disease, Parkinson's disease, Lewy body dementia, or mixed dementia, as defined by recognised psychiatric guidelines (DSM-5). - People whose score on a standard memory and think...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06631976 · Medical University of Lodz Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2026
🇵🇱 PL

**Who might be able to join this trial:** - People who have a partial tear of a specific shoulder tendon (the supraspinatus), where the tear is smaller than 1 cm and affects less than half the tendon's thickness, confirmed by an ultrasound scan - People whose shoulder pain has been disrupting their sleep for at least...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06634264 · Université de Montréal Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 March 2027
🇨🇦 CA

**Who might be able to join this trial:** - Your child shows signs of obstructive sleep apnea, such as snoring or breathing pauses during sleep noticed by others, confirmed by a score of 0.33 or higher on a standard children's sleep questionnaire - Your child is already scheduled to have their adenoids, tonsils, or bot...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06636006 · Universidade Federal de Goias Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2026
🇧🇷 BR

Who might be able to join this trial: - Adults aged 18 years or older - People who score above 8 on the Insomnia Severity Index, a questionnaire that measures how serious someone's sleep problems are - People who are considered physically inactive based on a standard activity questionnaire called the IPAQ Who may not...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06636318 · University of Chicago Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2027
🇺🇸 US

**Who might be able to join this trial:** - You must be a generally healthy person - You must be a surgery resident doctor who works 24-hour shift rotations - Both males and females are welcome to participate - You must be 18 years old or older - People of any racial or ethnic background are welcome to join **Who may...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06656533 · Stanford University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2026
🇺🇸 US

**Who might be able to join this trial:** - Men and women of any racial or ethnic background, between the ages of 25 and 45 (inclusive) - People who have been diagnosed with insomnia through a specific structured interview called the DUKE - People who are fluent in English and able to read and write in English - People...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06658158 · Xuanwu Hospital, Beijing Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2025
🇨🇳 CN

Who might be able to join this trial: - People who have been diagnosed with insomnia disorder based on standard diagnostic guidelines (DSM-5) - People whose sleep quality score on the PSQI questionnaire is above 5, indicating poor sleep - People who are 18 years of age or older and have completed at least a junior high...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06658184 · Xuanwu Hospital, Beijing Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2025
🇨🇳 CN

Who might be able to join this trial: - You have been diagnosed with insomnia disorder according to standard medical guidelines (DSM-5). - Your sleep quality score is above 5 on a standard questionnaire called the Pittsburgh Sleep Quality Index (PSQI), indicating poor sleep. - You are 18 years old or older and have com...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06668597 · Fondazione Don Carlo Gnocchi ETS Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2026
🇮🇹 IT

Who might be able to join this trial: - Adults who have been diagnosed with obstructive sleep apnea (OSA), a condition where breathing repeatedly stops and starts during sleep, ranging from mild to severe - People with sleep apnea who are about to start getting used to a CPAP machine (a breathing device worn during sle...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06668623 · TC Erciyes University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 May 2025
Turkey (Türkiye)

Who might be able to join this trial: - People who are over 18 years of age - People who have no communication difficulties - People who communicate in Turkish - People who do not have a diagnosed mental illness - People who are willing to take part in the study - People who are able to understand and complete forms an...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06669507 · St. Olavs Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2030
🇳🇴 NO

Who might be able to join this trial: - People who have been referred to the Sleep Clinic at St. Olavs Hospital for an assessment of a sleep or wakefulness problem. - People who are 18 years of age or older. - People who are willing and able to sign a written consent form to participate. - People who have been diagnose...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06677268 · University Hospital, Rouen Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 February 2028
🇫🇷 FR

**Who might be able to join this trial:** - People aged 50 or older, of any sex - People who have been diagnosed with COPD (a chronic lung condition) according to recognised 2022 medical guidelines, whose condition is currently stable (no flare-ups in the last 4 weeks), and who have been recommended for breathing reha...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06679543 · University of Guelph Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇨🇦 CA

Who might be able to join this trial: - People with no known heart, blood vessel, or metabolic conditions (such as diabetes), and no sleep disorders - People who have not smoked in the past 3 months - People who are cleared for physical activity based on a standard health readiness questionnaire called the PAR-Q+ - Peo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06681974 · Instituto de Investigación Marqués de Valdecilla Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 May 2024
🇪🇸 ES

**Who might be able to join this trial:** - People who have been diagnosed with mild to moderate sleep apnoea (a condition where breathing repeatedly stops and starts during sleep) that does not meet the guidelines for treatment with a CPAP machine or a special dental device (called a mandibular advancement device) - P...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06687304 · Lund University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 March 2027
🇸🇪 SE

"Who might be able to join this trial: - People who work as a radiographer (a healthcare professional trained to perform medical imaging examinations) Who may not be able to join: - No specific exclusion criteria have been listed for this trial (confirm with trial site) Important: Always verify eligibility with the t...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06694441 · Northwestern University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 July 2029
🇺🇸 US

Who might be able to join this trial: - People aged 55 or older. - People who are able to manage their own daily activities independently and who score 26 or higher on a standard memory and thinking test. - Women who have been through menopause (this applies because hormonal changes can affect sleep and the body's inte...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06697158 · Abant Izzet Baysal University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 12 December 2026
Turkey (Türkiye)

Who might be able to join this trial: - You are between 18 and 85 years old - You have been diagnosed with swelling (lymphedema) in one arm following breast cancer surgery - A doctor has confirmed your lymphedema is at stage 2 - You are willing to voluntarily agree to take part in the study Who may not be able to join...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06698809 · NYU Langone Health Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2026
🇺🇸 US

Who might be able to join this trial: - People who have normal cognitive function, as measured by a telephone-based memory and thinking test (score of 29 or higher). - People who have been diagnosed with moderate to severe obstructive sleep apnea (a condition where breathing repeatedly stops during sleep). - People who...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06701396 · Vanda Pharmaceuticals Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 30 June 2025
Turkey (Türkiye)

Who might be able to join this trial: - You are willing and able to sign a consent form agreeing to take part in the study. - You have been officially diagnosed with Delayed Sleep-Wake Phase Disorder (DSWPD), a condition where you naturally fall asleep and wake up much later than normal. - You carry a specific gene var...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06705400 · University of Southern Denmark Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 March 2029
🇩🇰 DK

Who might be able to join this trial: - Children born to first-time mothers who were at 20 weeks of pregnancy between November 1st, 2024 and October 31st, 2025. Who may not be able to join: - Families who are not able to receive digital mail or communications (such as emails or electronic messages). Important: Always...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06706349 · Centre Hospitalier Universitaire de Besancon Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2027
🇫🇷 FR

Who might be able to join this trial: - People aged 18 to 65 years old - People who have been assessed as having Alcohol Use Disorder (AUD), meeting at least 2 criteria as defined by a standard diagnostic tool called DSM-5 - People who have sleep problems, scoring 5 or higher on a standard sleep quality questionnaire c...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06715228 · Cairo University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 April 2025
🇪🇬 EG

Who might be able to join this trial: - People who are not classified as obese - People who have been diagnosed with obstructive sleep apnea in a mild or moderate form Who may not be able to join: - People who have heart (cardiac) conditions - People who have metabolic diseases (such as diabetes or thyroid disorders)...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06720545 · Columbia University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2027
🇺🇸 US

**Who might be able to join this trial:** - Adults aged 18 or older who speak English and whose sleep apnea treatment with a hypoglossal nerve stimulator (HGNS) — a device implanted to treat sleep apnea — has been working well, meaning it has reduced their breathing interruptions during sleep by at least 50% to below...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06721819 · Beth Israel Deaconess Medical Center Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 30 June 2029
🇺🇸 US

**Who might be able to join this trial:** - You are scheduled to have heart surgery (bypass surgery with or without valve work, or valve surgery alone) that requires opening the breastbone and using a heart-lung bypass machine, and your surgery is planned at least 10 days from now. - You are 60 years of age or older. -...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06725979 · University of Rijeka Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2025
🇭🇷 HR

**Who might be able to join this trial:** - People who have a narrow upper jaw (a palate or upper jaw that is considered too narrow, often requiring expansion treatment) **Who may not be able to join:** - People who have one or more missing teeth that never developed (a condition where some adult teeth are congenitall...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06732284 · Centre Hospitalier Universitaire de Nīmes Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2027
🇫🇷 FR

**Who might be able to join this trial:** - You have given your free and informed agreement to take part and signed a consent form - You are covered by a health insurance plan - You are able to understand, read, and write in French - *(For people with depression)* You have been diagnosed with depression based on stand...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06736444 · University of Washington Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2029
🇺🇸 US

**Who might be able to join this trial:** - You are between 18 and 29 years old - You currently live in Washington State - You have a valid email address - You have at least moderate sleep problems, such as trouble falling asleep, staying asleep, or waking up too early (based on a standard sleep questionnaire score) -...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06736951 · Farhaan S. Vahidy Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 March 2029
🇺🇸 US

Who might be able to join this trial: - People aged 70 years or older - People of any sex - People of any race or ethnicity - People who have been admitted to one of the specific hospital units taking part in this study Who may not be able to join: - People who are going through withdrawal from alcohol or other substa...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06740188 · Tongji University Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 31 December 2026
🇨🇳 CN

**Who might be able to join this trial:** - People who are either currently admitted to hospital or attending as an outpatient - People aged 18 to 65 years old - People who have been formally diagnosed with both depression and non-organic insomnia (sleep problems not caused by a physical condition) according to the DSM...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06743373 · University of Pittsburgh Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 January 2029
🇺🇸 US

**Who might be able to join this trial:** - You are between 18 and 25 years old - You are in good physical and mental health - *(Cannabis-using group only)* You have been using cannabis frequently (6 or more days per month) or daily for the past 3 months - *(Cannabis-using group only)* You are willing to stop using ca...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06745349 · University of Regina Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇨🇦 CA

Who might be able to join this trial: - People who are 18 years of age or older - People who are living in Saskatchewan for the full duration of the treatment period - People who report having trouble sleeping, such as difficulty falling asleep, staying asleep, or waking up too early, and whose sleep problems cause dis...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06747689 · Dokuz Eylul University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 20 June 2025
Turkey (Türkiye)

Who might be able to join this trial: - People who have been diagnosed with heart failure based on international medical guidelines - People who are 18 years of age or older - People who are able to have a conversation over the phone - People who are willing to take part in the study Who may not be able to join: - Peo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06749444 · Jimmi Nielsen Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2026
🇩🇰 DK

Who might be able to join this trial: - You have been diagnosed with schizophrenia, chronic paranoid psychosis, schizo-affective disorder, or another related non-organic psychosis condition - Your psychosis has not responded well to standard treatments, meeting specific research criteria for "treatment resistance" (con...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06749951 · Vestre Viken Hospital Trust Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 June 2026
🇳🇴 NO

**Who might be able to join this trial:** - People aged between 18 and 75 years who are willing to give written agreement to participate - People who were hospitalised at Drammen Hospital between 2021 and 2024 with a heart attack, confirmed narrowing of the heart's arteries, or who had a procedure to reopen blocked he...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06750796 · Tanta University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 June 2025
Turkey (Türkiye)

Who might be able to join this trial: - You are between 18 and 45 years old - You had a single baby born at 37 weeks of pregnancy or later - Your pregnancy was uncomplicated and you delivered either vaginally or by cesarean section - You do not smoke, drink alcohol, or use stimulants - Your Body Mass Index (BMI) is und...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06751992 · Massachusetts General Hospital Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 May 2027
🇺🇸 US

Who might be able to join this trial: - People who are able to give their informed consent to take part in the study - People who have regular outpatient follow-up appointments at the Massachusetts General Hospital (MGH) transplant center - People who had their most recent kidney transplant at least 1 year ago - People...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06754722 · 5 Point App, Inc. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2027
🇺🇸 US

Who might be able to join this trial: - People who currently have cancer or have previously been treated for cancer - People who experience at least a moderate level of fatigue, meaning a score of more than 4 out of 10 on a fatigue scale - People who are able to read and speak English - People who are 18 years of age o...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06755840 · Xiangya Hospital of Central South University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2030
🇨🇳 CN

Who might be able to join this trial: - People who are suspected of having a sleep breathing problem and have completed at least one overnight sleep monitoring session at the Sleep Medicine Center at Xiangya Hospital. - People who are able to complete assessments — such as questionnaires, physical examinations, and tes...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06767137 · Christoph Nissen Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2027
🇨🇭 CH

Who might be able to join this trial: - People who have been diagnosed with insomnia disorder according to standard diagnostic guidelines (DSM-5) - Adults between the ages of 18 and 80 years - People who are able to read and sign a consent form agreeing to take part in the study - People who speak German or French well...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06768190 · Chinese University of Hong Kong Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 January 2026
Hong Kong

Who might be able to join this trial: - People who are pregnant, between 12 and 28 weeks along, along with their partners who are over 18 years old - People who are able to read and understand Chinese - People who have a smartphone or electronic device with WhatsApp and internet access - People who are able to give wri...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06768749 · University of Redlands Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2028
🇺🇸 US

**Who might be able to join this trial:** - People who score 48 or higher on a standard questionnaire measuring sleep disturbance (called the PROMIS sleep disturbance short form) - People who score 55 or higher on a standard questionnaire measuring anxiety or depression (called the PROMIS anxiety or depression short fo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06773143 · Nanjing First Hospital, Nanjing Medical University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇨🇳 CN

**Who might be able to join this trial:** - People who have been diagnosed with breast cancer, confirmed through lab and tissue testing - People who are currently receiving chemotherapy before surgery (known as neoadjuvant chemotherapy) - People aged between 18 and 65 years old - People rated as ASA Grade I to III, whi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06781203 · Aarhus University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 November 2026
🇩🇰 DK

Who might be able to join this trial: - Adults aged 18 years or older - People experiencing moderate-to-severe insomnia symptoms, as measured by a score of 10 or higher on a standard insomnia questionnaire called the Insomnia Severity Index (ISI) - People who have been referred to the trial by their general practitione...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06783725 · University of Alabama at Birmingham Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇺🇸 US

Who might be able to join this trial: - People who have a confirmed diagnosis of Down syndrome. - People from households where English is the main language spoken at home. - People who have a nonverbal mental age of at least 36 months, measured through an assessment of everyday adaptive skills at the start of the trial...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06788288 · University of Thessaly Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 December 2025
🇬🇷 GR

**Who might be able to join this trial:** - People who score 16 or higher on a standard sleep questionnaire called the Athens Insomnia Scale, which measures how severely someone is affected by insomnia **Who may not be able to join:** - People who have a history of mental illness - People who have a history of epileps...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06789250 · Linkoeping University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2025
🇸🇪 SE

Who might be able to join this trial: - People aged 18 or older - People whose score on the AUDIT alcohol questionnaire is 6 or higher (for women) or 8 or higher (for men) — this is a standard screening tool for alcohol use (confirm with trial site) - People experiencing symptoms of depression, anxiety, or stress-relat...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06791356 · Rutgers, The State University of New Jersey Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇺🇸 US

**Who might be able to join this trial:** - People who can read at around a 6th-grade level and can speak and understand English well. - People who identify as African American or Black. - People aged 60 or older. - People whose sleep questionnaire results show problems with sleep duration, sleep disturbances, or over...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06792045 · Université Catholique de Louvain Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2027
🇧🇪 BE

Who might be able to join this trial: - Children and teenagers between 6 and 17 years old - Those who have been medically diagnosed with obstructive sleep-disordered breathing (a condition where breathing is repeatedly blocked during sleep) that requires surgical removal of the tonsils (partially or fully) and/or adeno...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06792188 · Seoul National University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇰🇷 KR

**Who might be able to join this trial:** - Men and women between the ages of 22 and 85 who visited Seoul National University Hospital with suspected sleep apnea, based on symptoms such as snoring, pauses in breathing during sleep, or feeling excessively sleepy during the day. **Who may not be able to join:** - People...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06801366 · Children's Hospital of Eastern Ontario Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2028
🇨🇦 CA

Who might be able to join this trial: - The patient is between 2 and 18 years old - The patient has been referred to a specialist hospital centre for a sleep study to check for obstructive sleep apnea (a condition where breathing is interrupted during sleep) - The parent or caregiver has access to a smartphone or other...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06807086 · Massachusetts General Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 January 2028
🇺🇸 US

Who might be able to join this trial: - People who have had a non-spreading (non-metastatic) cancer — either a solid tumour or blood cancer — and have finished their main cancer treatments such as radiation, surgery, or chemotherapy (ongoing hormonal, maintenance, oral, or immunotherapy is still permitted) - People who...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06808464 · University Hospital, Lille Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 February 2027
🇫🇷 FR

Who might be able to join this trial: **Healthy volunteers (Group 1):** - People who have no known sleep disorders, based on several standard sleep questionnaires showing normal results - People who score below 11 on the Epworth Sleepiness Scale (a questionnaire measuring daytime sleepiness) - People who score below 6...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06809335 · Henry Ford Health System Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2027
🇺🇸 US

Who might be able to join this trial: - People who regularly sleep less than 7 hours during the day (after night shifts) - People who are willing to download an app called SHIFT and follow its lighting recommendations - People who are able to stick to a set sleep schedule of 7 hours in bed after working night shifts -...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06810180 · Hugo W. Moser Research Institute at Kennedy Krieger, Inc. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 April 2030
🇺🇸 US

Who might be able to join this trial: **For the ADHD group:** - You (or your child) must have been diagnosed with ADHD based on standard diagnostic guidelines (DSM-5) **For the control (comparison) group:** - You (or your child) must not have a diagnosis of any psychological, neuropsychological, or intellectual condi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06813235 · The University of Hong Kong Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 2 February 2027
Hong Kong

Who might be able to join this trial: - You speak Cantonese or Mandarin and have been diagnosed with breast, colorectal, or gynaecological cancer that can be cured. - You finished your main cancer treatment (not including hormone therapy) within the last two years. - You have mild to moderate sleep problems, as measure...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06814886 · Tri-Service General Hospital (TSGH) Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 January 2027
🇹🇼 TW

Who might be able to join this trial: - People aged 20 years or older who are willing to give their consent to take part in the study. - People who own a smartphone and are willing to join the study's LINE group (a messaging app). - People whose smartphone app is compatible with the Fitbit Charge 6 wearable fitness dev...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06824415 · Stanford University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 May 2028
🇺🇸 US

Who might be able to join this trial: - Adults between 18 and 65 years old - People who have been diagnosed with Major Depressive Disorder (a medical diagnosis of serious, ongoing depression) - People whose depression is currently rated as moderate to severe - People who have tried at least one antidepressant medicatio...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06828276 · Karolinska Institutet Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇸🇪 SE

Who might be able to join this trial: - People between the ages of 15 and 29. - People who score above 1.75 on a mental health questionnaire called the HSCL-25, which measures anxiety and depression symptoms. - People who have a refugee or migrant background. - People who have a reliable and steady internet connection....

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06828835 · Medical University of South Carolina Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 August 2028
🇺🇸 US

Who might be able to join this trial: - You are a parent or caregiver aged 18 or older of a child who has been referred by a primary care doctor to see a sleep specialist or ear, nose, and throat (ENT) doctor for a possible sleep breathing problem - Your child is between 2 and 11 years old (up to but not including thei...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06832007 · University of Alabama at Birmingham Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 16 September 2028
🇺🇸 US

**Who might be able to join this trial:** **All participants must meet these criteria:** - Between 18 and 60 years old - Fluent in English - Able to sign a written consent form agreeing to take part **For people with Opioid Use Disorder (OUD) — an additional set of criteria applies:** - A formal diagnosis of Opioid U...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06833710 · Mackay Memorial Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇹🇼 TW

Who might be able to join this trial: - People who are 18 years of age or older - Nurses whose score on the Pittsburgh Sleep Quality Index is greater than 5 (this scale measures sleep quality, and a higher score suggests poorer sleep) - People who are alert and able to communicate in Mandarin or Taiwanese, can complete...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06834724 · Vrije Universiteit Brussel Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇧🇪 BE

Who might be able to join this trial: - People who are 18 years of age or older - People who can read and write in Dutch, French, or English - People who have been diagnosed with obstructive sleep apnoea (OSA) that is considered clinically significant, meaning their sleep apnoea score (called an AHI) is 15 or higher -...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06844981 · Rutgers, The State University of New Jersey Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇺🇸 US

**Who might be able to join this trial:** - People who are 18 years of age or older - People who self-identify as Hispanic and/or Latino(a) - People who have a confirmed diagnosis of a solid tumour or a blood cancer - People who finished their main cancer treatment (such as chemotherapy, surgery, or radiation) at least...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06848647 · Uppsala University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 20 December 2027
🇸🇪 SE

Who might be able to join this trial: - You have been diagnosed with obstructive sleep apnea (a condition where breathing repeatedly stops and starts during sleep) - You are planned to start CPAP treatment (a machine that helps you breathe while you sleep) - You are 18 years old or older Who may not be able to join: -...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06851338 · Inspire Medical Systems, Inc. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2030
🇺🇸 US

**Who might be able to join this trial:** - The person has been diagnosed with Down syndrome - The person is between 13 and 18 years old - The person has been diagnosed with severe obstructive sleep apnea, confirmed by a sleep study done in a clinic within the last 6 months, with a specific sleep apnea score (AHI) bet...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06853106 · Taipei Medical University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 28 February 2027
🇹🇼 TW

Who might be able to join this trial: - People who are enrolled as a full-time student - People aged 18 to 26 years old - People who have been experiencing sleep difficulties (insomnia) for at least three months - People who currently own and regularly use a personal mobile device - People who are able to read and spea...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06859892 · Peking University First Hospital Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 November 2026
🇨🇳 CN

**Who might be able to join this trial:** - People aged 18 or older - People who are scheduled for a major non-heart surgery lasting at least 60 minutes under general anaesthesia, with the surgery expected to finish by 6:00 pm - People who are planned to use a self-controlled pain relief drip (where the patient can pre...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06861998 · Yan Fuxia Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇨🇳 CN

Who might be able to join this trial: - Children aged 0 to 3 years old - Children who are scheduled to have planned (non-emergency) surgery to correct a heart condition they were born with, where a heart-lung bypass machine will be used during the operation - Children who have been identified as having sleep problems b...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06862297 · Taipei Medical University WanFang Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 2 September 2025
🇹🇼 TW

**Who might be able to join this trial:** - People between the ages of 20 and 75 years old - People who have been referred by a healthcare professional because sleep apnea is suspected, based on signs such as excessive daytime sleepiness, loud snoring, breathing pauses during sleep, or a high-risk result on a standard...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06866834 · Gulhane School of Medicine Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2025
Turkey (Türkiye)

Who might be able to join this trial: **Group 1 – People with nocturia (waking at night to urinate):** - Women aged 18 or older who have been diagnosed with urinary incontinence - People who wake up during their main sleep period specifically to urinate, intending to return to sleep afterward **Group 2 – People witho...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06872593 · Stefan Lakämper Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 April 2027
🇨🇭 CH

Who might be able to join this trial: **For people with sleep apnoea (OSA):** - Adults who hold a driver's licence - People who have been diagnosed with obstructive sleep apnoea (OSA) - People who are already on an established CPAP treatment routine (a machine that helps with breathing during sleep) - People who have...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06875479 · Shanghai 6th People's Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2025
🇨🇳 CN

**Who might be able to join this trial:** - People aged 18 to 70 who have possible symptoms such as snoring at night, feeling sleepy during the day, or feeling like they sleep poorly, and who are suspected of having obstructive sleep apnoea (OSA). - People who are willing to have an overnight sleep study (a test that m...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06875908 · Istanbul Medeniyet University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 20 July 2025
Turkey (Türkiye)

**Who might be able to join this trial:** - You are 18 years old or older and have been diagnosed with Multiple Sclerosis for at least two years - Your level of physical disability has been measured above a certain point using a standard MS disability scale (EDSS score greater than 2) (confirm with trial site) - You do...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06892158 · Children's Hospital of Philadelphia Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2028
🇺🇸 US

Who might be able to join this trial: - People who have been diagnosed with cancer, such as acute myeloid leukemia (AML) or relapsed acute lymphoblastic leukemia (rALL), or who are admitted to receive a stem cell transplant (using either their own cells or a donor's cells) for any reason - People who are expected to st...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06896448 · University Hospital, Caen Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 16 September 2027
🇫🇷 FR

Who might be able to join this trial: - Adults who are being investigated for a suspected cancer in the head or neck area, where the cancer is then confirmed — this includes cancers in the nasopharynx, nasal cavities, sinuses, mouth, throat, voice box, or parotid gland (a saliva gland near the ear). - People who are wi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06902285 · University of Miami Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 July 2026
🇺🇸 US

**Who might be able to join this trial:** - People who are having their first total knee or hip replacement surgery at the University of Miami Hospital - People who are older than 18 years of age - People who are able to understand and sign a consent form agreeing to take part - People who speak English or Spanish **W...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06910930 · Thammasat University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 March 2026
🇹🇭 TH

**Who might be able to join this trial:** - People who have been diagnosed with mild to moderate obstructive sleep apnea. - People who are 18 years of age or older. - People who are willing to voluntarily give consent to share their information for research purposes. **Who may not be able to join:** - People whose sle...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06912334 · National and Kapodistrian University of Athens Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇬🇷 GR

**Who might be able to join this trial:** - You are a woman between 18 and 79 years old - You have been diagnosed with Fibromyalgia using the ACR 2016 guidelines (confirm with trial site) - You have had moderate to severe pain (rated above 4 out of 10) for more than 6 months - You are able to understand the study instr...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06916936 · Florida State University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2027
🇺🇸 US

**Who might be able to join this trial:** - Children who are currently enrolled in elementary or middle school (grades 1 through 8) - Children who are between 6 and 13 years old - Children who are able to speak and read in English **Who may not be able to join:** - Children who have taken antibiotics in the past 3 m...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06926036 · Northwestern University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2027
🇺🇸 US

Who might be able to join this trial: - You are right-handed, speak English, are between 18 and 60 years old, and have normal hearing while you sleep - You either have been diagnosed with obstructive sleep apnea (a condition where breathing repeatedly stops during sleep) by a doctor, or a short questionnaire suggests y...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06928168 · Centre Hospitalier Universitaire de Saint Etienne Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2028
🇫🇷 FR

Who might be able to join this trial: - People who have signed a written consent form agreeing to take part. - Men or women are eligible. - People aged between 18 and 50 years old. - People who are physically active and go running at least once a week for more than one hour per session. - People who have not taken part...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06931028 · Innovent Biologics (Suzhou) Co. Ltd. Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 7 May 2027
🇨🇳 CN

**Who might be able to join this trial:** *For people currently using PAP therapy (such as CPAP):* - People who have been using PAP therapy continuously for at least 3 months before the screening visit and plan to keep using it during the study. *For people not using PAP therapy:* - People who are unable or unwilling...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06942455 · Rhode Island Hospital Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 31 March 2029
Puerto Rico🇺🇸 US

Who might be able to join this trial: - Children who are in middle school and between 11 and 13 years old - Children who live and attend school in one of the school districts selected for this study - Children who sleep an average of 9 hours or less per night Who may not be able to join: - Children who have a medical,...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06949280 · Rutgers, The State University of New Jersey Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇺🇸 US

**Who might be able to join this trial:** - Men and postmenopausal women (more than 2 years since their last period) between the ages of 50 and 75 - People with a body mass index (a measure of body weight relative to height) between 25 and 42, or who show early signs of obesity - People who are willing to be randomly...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06949644 · Northwestern University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 July 2029
🇺🇸 US

Who might be able to join this trial: - You have been diagnosed with delayed sleep-wake phase disorder (a condition where your natural sleep and wake times are significantly later than normal) Who may not be able to join: - You are currently taking any medications known to change the size of your pupils - You have a h...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06949722 · National University of Singapore Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 August 2027
🇸🇬 SG

Who might be able to join this trial: - You are willing to wear a ring on your finger - You have been diagnosed with high blood pressure - You have been diagnosed with high cholesterol - You have been diagnosed with a fatty liver - You have a family history of heart disease or stroke - You are living with obesity Who...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06953869 · Vanda Pharmaceuticals Phase 3 · 4 countries Recruiting
Recruiting Phase 3 Est. completion 1 November 2027
🇩🇪 DE🇵🇱 PL🇬🇧 GB🇺🇸 US

Who might be able to join this trial: - You (or your child) must be willing and able to sign a consent form, or have a legal guardian do so on their behalf. - You (or your child) must have a confirmed diagnosis of insomnia disorder. - The participant must be a male or female between the ages of 2 and 17 years old (incl...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06956118 · Neurovalens Ltd. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇮🇳 IN

Who might be able to join this trial: - People who have signed an informed consent form agreeing to take part in the study - People aged between 20 and 60 years old at the time of signing the consent form - People who score 5 or higher on a standard sleep quality questionnaire (called the PSQI) at the screening and bas...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06959069 · Université Libre de Bruxelles Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 May 2026
🇧🇪 BE

Who might be able to join this trial: - People who are generally healthy with no significant medical conditions - Adults between 18 and 65 years old - People with a body mass index (BMI) between 18.5 and 29.9, which falls in the normal to overweight range - Both men and women are eligible Who may not be able to join:...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06960161 · University of Alberta Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 31 December 2030
🇨🇦 CA

Who might be able to join this trial: - People who are currently using a CPAP machine (a breathing device worn during sleep) - People who are having trouble tolerating their CPAP machine or who experience snoring Who may not be able to join: - People who are not currently using a CPAP machine Important: Always verify...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06960200 · University of Alberta Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 December 2030
🇨🇦 CA

**Who might be able to join this trial:** - People who have been diagnosed with obstructive sleep apnea (OSA), which is a condition where breathing repeatedly stops and starts during sleep - People whose sleep apnea has not been fully treated by an oral appliance therapy device (a mouthguard-like device worn during sle...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06963463 · University of Pittsburgh Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇺🇸 US

Who might be able to join this trial: - Adolescents between the ages of 12 and 18 years old - People who are currently experiencing moderate to severe depression, based on a score of 11 or higher on a standard depression questionnaire called the PHQ-9M - People who are currently having significant sleep problems, based...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06966921 · Liu Hsing Yu Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2025
🇹🇼 TW

Who might be able to join this trial: - People who have a long-term (chronic) mental illness - People who score 16 points or higher on a standard memory and thinking test called the Mini-Mental State Examination (MMSE) - People who have completed at least a junior high school level of education - People who are able to...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06967922 · Xuanwu Hospital, Beijing Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2025
🇨🇳 CN

**Who might be able to join this trial:** - People who have been diagnosed with insomnia disorder according to standard psychiatric diagnostic guidelines (DSM-5) - People who score more than 5 out of 21 on a standard sleep quality questionnaire called the Pittsburgh Sleep Quality Index, indicating poor sleep quality -...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06967974 · Xuanwu Hospital, Beijing Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2025
🇨🇳 CN

**Who might be able to join this trial:** - People who have been diagnosed with insomnia disorder according to standard psychiatric diagnostic guidelines (DSM-5) - People whose sleep quality score on a standard questionnaire (called the Pittsburgh Sleep Quality Index) is above 5, indicating poor sleep - People who are...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06968000 · Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 March 2026
🇪🇸 ES

**Who might be able to join this trial:** - You are 18 years old or older, regardless of whether you are male or female - You are scheduled for a planned (non-emergency) general surgery, ideally involving the liver or bile duct area - You are expected to stay in the hospital for at least 4 days after your surgery in a...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06968013 · Xuanwu Hospital, Beijing Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2025
🇨🇳 CN

**Who might be able to join this trial:** - People who have been diagnosed with Insomnia Disorder (as defined by DSM-5 medical guidelines) for at least 3 months - People whose sleep quality scores above 5 on a standard sleep quality measurement tool called the Pittsburgh Sleep Quality Index (PSQI) - People aged 8 years...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06968299 · SunWay Biotech Co., LTD. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2025
🇹🇼 TW

**Who might be able to join this trial:** - People who are 18 years of age or older, mentally alert, and able to communicate clearly. - People who agree to take part in the trial and are willing to sign a consent form. **Who may not be able to join:** - People who are pregnant or are expected to become pregnant (based...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06969040 · Xuanwu Hospital, Beijing Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2025
🇨🇳 CN

Who might be able to join this trial: - People who meet the standard diagnostic criteria for insomnia as defined in the DSM-5 (a widely used medical manual for diagnosing mental health conditions) - People who score more than 5 points on the Pittsburgh Sleep Quality Index, a standard questionnaire used to measure sleep...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06969053 · Xuanwu Hospital, Beijing Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2025
🇨🇳 CN

**Who might be able to join this trial:** - You have been diagnosed with Insomnia Disorder based on standard medical guidelines (DSM-5). - You scored higher than 5 on a standard sleep quality questionnaire called the Pittsburgh Sleep Quality Index (confirm with trial site). - You are 8 years old or older. - You have co...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06972303 · Brigham and Women's Hospital Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 31 July 2028
🇺🇸 US

**Who might be able to join this trial:** - You are 18 years of age or older - You have had trouble sleeping at least 3 nights per week for at least 3 months, diagnosed as chronic insomnia - Your main sleep problem is difficulty falling asleep, and it typically takes you more than 20 minutes to fall asleep - Your score...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06974851 · Fujian Shengdi Pharmaceutical Co., Ltd. Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 December 2026
🇨🇳 CN

**Who might be able to join this trial:** - People aged 18 to 75 years old (male or female) who are willing to follow the study requirements from start to finish. - People with a body mass index (BMI) of 28.0 or higher at the screening visit. - People who have been following a controlled diet and exercise plan for at...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06975384 · Second Xiangya Hospital of Central South University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2029
🇨🇳 CN

**Cohort 1 (Non-small cell lung cancer – advanced, treated with immunotherapy)** Who might be able to join this trial: - Adults aged 18 or older - People with a confirmed diagnosis of non-small cell lung cancer (NSCLC), a common type of lung cancer - People whose cancer is at an advanced or spread stage (stage IIIB–IV...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06975709 · IRCCS San Raffaele Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇮🇹 IT

**Who might be able to join this trial:** - People who are over 18 years old - People of any gender (male or female) - People who are willing and able to sign a privacy information form - People who are willing and able to sign an informed consent form for the study - People who are able to understand the study and mak...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06976138 · Johns Hopkins University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 July 2029
🇺🇸 US

**Who might be able to join this trial:** - People who have been diagnosed with knee osteoarthritis - People who are 60 years of age or older - People who are scheduled to have a total knee replacement on one knee for osteoarthritis - People who have difficulty falling asleep or staying asleep **Who may not be able to...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06979258 · University of California, Berkeley Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 March 2029
Bangladesh

Who might be able to join this trial: - The house must be located in an informal settlement in an urban area in Bangladesh - The house must have a corrugated iron roof and corrugated iron walls - The household must plan to stay in the house from February to November - The person taking part must live in a house that me...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06981195 · Virginia Commonwealth University Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 30 July 2029
🇺🇸 US

**Who might be able to join this trial:** - You are 18 years of age or older - You have been diagnosed with opioid use disorder (OUD) of at least moderate severity, based on current diagnostic guidelines - You are currently receiving outpatient treatment for OUD using buprenorphine, either as a dissolvable film or tab...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06983080 · Centre hospitalier de l'Université de Montréal (CHUM) Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 July 2027
🇨🇦 CA

**Who might be able to join this trial:** - People aged 65 or older who are being seen in an outpatient setting (not currently admitted to hospital) - People who have been diagnosed with insomnia according to a specific set of recognised sleep disorder diagnostic guidelines (confirm with trial site) **Who may not be a...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06983275 · Jia Xiu Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2027
🇨🇳 CN

**Who might be able to join this trial:** - People aged 18 to 65 years, of any gender - People who have been diagnosed with chronic insomnia disorder (based on DSM-5 criteria), where the main problem is taking more than 30 minutes to fall asleep, happening 3 or more nights per week, for more than 3 months but less than...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06983431 · Slovak Academy of Sciences Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 5 May 2026
🇸🇰 SK

Who might be able to join this trial: - People with a body mass index (BMI) between 27 and 42, which is a measure of body weight relative to height that falls in the overweight to obese range - People who are able and willing to use a smartphone as part of the program - People who are able and willing to wear a fitness...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06983769 · National University Hospital, Singapore Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2030
🇸🇬 SG

Who might be able to join this trial: - People who are aged 45 or older and are of Chinese, Malay, or Indian ethnicity - People who have been referred to a sleep clinic at one of the participating study centres because sleep apnoea was suspected - People who have had a full overnight sleep study (done in a clinic) and...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06990256 · Huazhong University of Science and Technology Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 May 2026
🇨🇳 CN

**Who might be able to join this trial:** - You are between 30 and 75 years old - You scored more than 5 points on a standard sleep quality questionnaire called the Pittsburgh Sleep Quality Index, which suggests you may have poor sleep quality (confirm with trial site) - You are able to use a personal phone or device t...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06993207 · Bitbrain Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇪🇸 ES

**Who might be able to join this trial:** **General requirements for all participants:** - You are a native Spanish speaker. - You are willing to take part in tests and examinations as part of the study. - You are able to involve a close family member or friend to help with some assessments. - Your colour vision is no...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06994247 · University of Split, School of Medicine Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 December 2025
🇭🇷 HR

**Who might be able to join this trial:** - You are 18 years of age or older - You have been diagnosed with severe obstructive sleep apnea, meaning your breathing stops or becomes blocked frequently during sleep (at least 30 times per hour) - You are willing and able to sign a consent form agreeing to take part in the...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06995742 · Northwestern University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 July 2026
🇺🇸 US

Who might be able to join this trial: - People who are admitted as inpatients to Northwestern Memorial Hospital, Feinberg Unit 16 West. Who may not be able to join: - People whose primary language is not English. - People who are under isolation status in the hospital. - People who are pregnant. - People who are priso...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06999811 · Medical University of South Carolina Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 October 2028
🇺🇸 US

**Who might be able to join this trial:** - You are currently pregnant and between 13 weeks and 32 weeks and 6 days along in your pregnancy - You currently have, or have had in the past 3 years, an opioid use disorder (a dependence on or problematic use of opioids) - You have a prescription for a buprenorphine medicati...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07003399 · Nanjing Medical University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 August 2025
🇨🇳 CN

Who might be able to join this trial: - Adults between 18 and 80 years of age - People in the **OSA group**: those who have been diagnosed with obstructive sleep apnea, confirmed by an overnight sleep study showing 5 or more breathing interruption events per hour - People in the **COPD group**: those who have been diag...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07012967 · Elif Kabasakal Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 August 2025
Turkey (Türkiye)

Who might be able to join this trial: - Adults aged between 18 and 70 years old - People who are overweight or fall into obesity class 1 or class 2 based on their body mass index (BMI) - People who are able to follow instructions and take part in study activities - People who can speak and understand Turkish Who may n...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07018557 · University of Sao Paulo Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 June 2026
🇧🇷 BR

**Who might be able to join this trial:** - Adults between 30 and 75 years old - People with a body mass index (a measure of body weight relative to height) below 40 - People who are available and willing to take part in the study - People who have a history of high blood pressure and are already receiving regular trea...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT07021183 · University of Regina Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 March 2028
🇨🇦 CA

**Who might be able to join this trial:** - People who are 18 years of age or older - People who currently work or volunteer, or who have previously worked or volunteered, as a public safety personnel (such as police, firefighters, paramedics, or similar roles) - People who live in a Canadian province where the PSPNET...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07028190 · Beijing Tiantan Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 March 2027
🇨🇳 CN

**Who might be able to join this trial:** *For people with insomnia:* - Adults between 18 and 64 years old - People considered to be in generally good to mild-risk health, as assessed by a standard medical classification system (ASA physical status I–II) - People with a body mass index (BMI) between 15 and 30 - People...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07030556 · University Ghent Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2026
🇧🇪 BE

Who might be able to join this trial: - Students who are in their 1st or 2nd year of a secondary vocational education program - Teachers who were involved in delivering the intervention as part of this trial Who may not be able to join: - Students who took part in the co-creation process (the process of helping design...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07031349 · Konya Necmettin Erbakan Üniversitesi Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 August 2025
Turkey (Türkiye)

Who might be able to join this trial: - People who have a specific type of bite alignment issue known as a Class I malocclusion (where the upper and lower teeth don't fit together properly in a particular way) - People whose upper jaw is narrower than it should be - People aged between 15 and 18 years old - People who...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07032480 · Saglik Bilimleri Universitesi Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 22 June 2026
Turkey (Türkiye)

Who might be able to join this trial: - You are between 18 and 28 years old - You have no history of physical or mental health illness - You are able to understand and agree to the terms of the study by giving your consent - You are joining the study completely by your own free choice Who may not be able to join: - Yo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07035314 · Ain Shams University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2025
🇪🇬 EG

Who might be able to join this trial: - Children between 4 and 10 years old - Children who need their tonsils removed because of repeated throat infections — specifically, at least 7 episodes in the past year, or at least 5 episodes per year for 2 years, or at least 3 episodes per year for 3 years - Children who need t...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07036705 · University of California, San Francisco Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2027
🇺🇸 US

Who might be able to join this trial: - People aged 18 years or older - People who speak English - People who are willing to use birth control during the trial, if they were assigned female sex at birth - People who are willing to receive text messages from the study team during the trial - People who have access to a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07039500 · Peking University First Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 10 December 2025
🇨🇳 CN

**Who might be able to join this trial:** **All participants must meet these criteria:** - People aged between 20 and 60 years old - People with normal hearing, confirmed by a hearing test (confirm with trial site) - People who score 26 or above on a standard memory and thinking assessment called the MoCA - People who...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07045792 · Mustafa Kemal University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 November 2025
Turkey (Türkiye)

Who might be able to join this trial: - You are between 20 and 30 years old - You are able to read and write - You have scored 10 or above on a standard stress measuring questionnaire called the DASS-21 (confirm with trial site) - You are willing to take part in the study by choice Who may not be able to join: - You h...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07048340 · Tel Aviv University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2029
🇮🇱 IL

Who might be able to join this trial: - The child taking part must be between 7 and 11 years old - The child's parent or parents must be 18 years of age or older - The child must have been identified, through a clinical interview, as having chronic insomnia disorder — meaning sleep difficulties that happen at least 3 n...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07048600 · Babes-Bolyai University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2026
🇷🇴 RO

**Who might be able to join this trial:** - People who have been diagnosed with chronic insomnia by a healthcare professional, or who are identified as having chronic insomnia through an assessment carried out by the trial's clinical team - People aged 18 to 59 years old (inclusive) - People with none, minimal, or mild...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07057232 · Germans Trias i Pujol Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇪🇸 ES

Who might be able to join this trial: - Adults aged 18 years or older - People of either biological sex - People who have been diagnosed with ongoing, long-term pain that is not caused by cancer - People who are currently receiving care from a pain specialist or at a pain clinic - People who are able to understand what...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07062770 · Brigham and Women's Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇺🇸 US

**Who might be able to join this trial:** - You have been diagnosed with moderate to severe sleep apnea (stopping breathing 20 or more times per hour during sleep) - You currently use a CPAP machine or have used one in the past - Your CPAP pressure setting is no higher than 13 cmH2O, if you know this information (confi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07071181 · Sheffield Hallam University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2026
🇬🇧 GB

Who might be able to join this trial: - People aged between 40 and 70 years old - People who experience poor sleep, as measured by a standard sleep quality questionnaire (a score above 5 on the Pittsburgh Sleep Quality Index) - People with a body mass index (a measure of body weight relative to height) between 25 and 3...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07076342 · Stony Brook University Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 31 March 2030
🇺🇸 US

**Who might be able to join this trial:** - People who are able to understand and agree to participate in the study on their own behalf - People who are at least 18 years old - People who are in generally good physical health and do not have significant ongoing medical conditions - People who have been diagnosed with m...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT07082608 · Asian Institute of Gastroenterology, India Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 19 May 2029
🇮🇳 IN

**Who might be able to join this trial:** - People who are over 18 years old - People whose BMI falls within the obesity range for their ethnic background, but below 40 kg/m² - People who have been diagnosed with moderate to severe obstructive sleep apnea (a sleep breathing condition with an AHI score of 15 or higher)...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07084701 · Tao Liu Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇨🇳 CN

**Who might be able to join this trial:** - People who are college students aged 18 or older who gained entry through a standardised entrance examination - Students who have not failed any exams during their studies - People who are experiencing sleep deprivation - People who are in good general health, with no mental...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07085754 · Yuhui Qiu Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇨🇳 CN

**Who might be able to join this trial:** - People aged 18 to 40 years old, of any gender - People who are generally healthy, with no significant health problems found during a physical examination or based on their own reporting, and who are not taking any medications - People whose memory and thinking are considered...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07086612 · Fondation Hôpital Saint-Joseph Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2026
🇫🇷 FR

Who might be able to join this trial: - Children and young people between 6 and 16 years of age - People with a specific type of jaw or dental alignment issue where the upper and lower jaws are too narrow (this is the "CAS" group) - People with another type of dental alignment issue, such as a rotated tooth, crowded te...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07086742 · Pathway Medtech, LLC. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 December 2025
🇧🇪 BE

**Who might be able to join this trial:** - People who are generally healthy, with no major health conditions or only minor ones (classified as ASA health score I or II — confirm with trial site if unsure what this means) - People aged 18 to 65 years old - People who have agreed to take part and are willing to follow t...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07087587 · The Cleveland Clinic Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇺🇸 US

Who might be able to join this trial: - People who are able to give their informed consent to participate - People aged between 18 and 85 years old - People who have a type of irregular heart rhythm called paroxysmal atrial fibrillation that occurs frequently (at least 1% of the time as recorded by a device) - People w...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07089797 · The University of Hong Kong Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇨🇳 CN

**Who might be able to join this trial:** - People aged 18 or older - People who are an unpaid caregiver (such as a family member or friend) who lives with someone who has had cancer at any stage, and who provides at least 4 hours of care per day — if more than one caregiver is available for the same person with cancer...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07091149 · University of South Florida Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2027
🇺🇸 US

**Who might be able to join this trial:** - Children aged 6 to 12 years old - Children with a verbal reasoning score above 70, indicating enough verbal ability to take part in treatment sessions - Children who have a parent or legal guardian living in the same home who is also willing to take part - Children who have...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07101302 · Memorial University of Newfoundland Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2026
🇨🇦 CA

**Who might be able to join this trial:** - You are a cancer survivor - You are 18 years of age or older - You currently live in Canada - You speak and understand English or French fluently - You have been formally diagnosed with insomnia (a sleep condition involving difficulty falling or staying asleep), as defined by...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07101796 · Peking University First Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2025
🇨🇳 CN

**Who might be able to join this trial:** - People between the ages of 18 and 70 years old - People who have symptoms that suggest sleep apnoea (such as snoring, waking during the night, or feeling sleepy during the day), people who need sleep apnoea screening because of a related health condition, or people who have a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07105345 · Far Eastern Memorial Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2027
🇹🇼 TW

**Who might be able to join this trial:** - People aged between 20 and 65 years old - People who have been diagnosed with PTSD (Post-Traumatic Stress Disorder) based on a standard set of diagnostic guidelines called DSM-5 - People whose PTSD symptoms score 33 or higher on a standard PTSD symptom checklist called the PC...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07106385 · The University of Hong Kong Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 27 June 2027
Hong Kong

Who might be able to join this trial: - Adults who are generally in good health - People aged between 18 and 65 years old - People who have noticed and reported problems with their sleep Who may not be able to join: - People who have a serious mental health condition other than primary insomnia (a sleep disorder on it...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07113288 · Inspire Medical Systems, Inc. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2032
🇺🇸 US

**Who might be able to join this trial:** - People aged 18 or older. - People who have been diagnosed with severe sleep apnoea (a specific severity score between 65 and 100) based on a sleep study done within the last 12 months, OR people diagnosed with moderate to severe sleep apnoea (a score between 15 and 100) who...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07119567 · Hôpital le Vinatier Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 September 2028
🇫🇷 FR

Who might be able to join this trial: - You are a man or woman aged 18 or older - You have been diagnosed with cocaine use disorder according to standard medical guidelines (DSM-5) - A urine test has come back positive for cocaine - You are planned to go through an inpatient (hospital-based) cocaine detox programme wit...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07120061 · University Hospital, Bordeaux Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2027
🇫🇷 FR

**Who might be able to join this trial:** - People who are covered by a social security system - People who have been fully informed about the study and have given their written, signed consent to take part - People who are suspected of having sleep apnea (a condition where breathing stops and starts during sleep) but...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07120373 · University of Nottingham Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇬🇧 GB

**Who might be able to join this trial:** This trial has two main groups for patients, plus a group for healthcare professionals. The criteria for each are listed below. **Part 1 – People with a recent brain injury:** - People aged 18 to 60 years old - People who have come to the Emergency Department within 24 hours...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07122505 · University Ghent Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2026
🇧🇪 BE

Who might be able to join this trial: - Children between the ages of 4 and 18 years old - Children who have been diagnosed with either Down syndrome or Prader-Willi syndrome - Children who have been diagnosed with Obstructive Sleep Apnea (a condition where breathing is interrupted during sleep) confirmed by a sleep stu...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07122921 · Chinese University of Hong Kong Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 January 2026
Hong Kong

**Who might be able to join this trial:** - Children who have been diagnosed with cancer (such as leukaemia, lymphoma, or solid tumours), are currently in hospital receiving cancer treatment (such as chemotherapy or radiation), and whose parent, guardian, or the child themselves can reliably report on the child's slee...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07128927 · Georgetown University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2026
🇺🇸 US

Who might be able to join this trial: - People aged 21 years or older - People who identify as Black or African American - People who have been diagnosed with invasive prostate cancer (any stage from I to IV) within the last 5 years - People who have not had surgery, chemotherapy, or radiation treatment in the past 3 m...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07129967 · University Ghent Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2026
🇧🇪 BE

Who might be able to join this trial: - Children who are between 6 and 12 years old - Children who have been diagnosed with Obstructive Sleep Apnea (a condition where breathing repeatedly stops during sleep) confirmed by a sleep study, with a specific severity score of less than 1 on that test Who may not be able to j...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07143266 · Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2027
🇪🇸 ES

**Who might be able to join this trial:** - People who have been diagnosed with hypothalamic-pituitary dysfunction, meaning a problem affecting the hypothalamus and/or pituitary gland, with at least one hormone that the pituitary is not producing properly, AND at least one sign of damage to the hypothalamus (for examp...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07143838 · Wake Forest University Health Sciences Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2027
🇺🇸 US

**Who might be able to join this trial:** - You are able to complete an overnight sleep study, including having small sensors placed on your head to measure brain activity. - You can read and understand English. - You have been diagnosed with moderate depression. - You have noticed problems with your memory or thinking...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07156383 · University of Notre Dame Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 August 2027
🇺🇸 US

**Who might be able to join this trial:** - People who are 18 years of age or older - People who speak English - People who have been identified as having Insomnia Disorder based on standard diagnostic criteria (DSM-5), first through a screening process and then confirmed in a brief clinical interview **Who may not be...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07156708 · Federal University of Pelotas Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2027
🇧🇷 BR

**Who might be able to join this trial:** - Women between the ages of 60 and 75 years old - People who have not been doing regular physical exercise for at least the past six months (where "regular" means doing any physical activity for 20 minutes or more, on at least two days per week) **Who may not be able to join:*...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07162675 · Ankara Etlik City Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 29 August 2026
Turkey (Türkiye)

Who might be able to join this trial: - People who are female and aged 18 years or older. - People who have been diagnosed with breast cancer that has not spread to other parts of the body, and whose cancer has tested negative for the HER2 protein. - People who are planned to receive treatment to shrink the cancer befo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07172607 · TCI Co., Ltd. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 April 2026
🇹🇼 TW

**Who might be able to join this trial:** - People aged 18 years or older, of any gender - People who have been formally diagnosed with Insomnia Disorder according to standard psychiatric diagnostic criteria (DSM-5) - People who have a regular bedtime between 9:00pm and 1:00am, and a regular wake-up time - People whose...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07172880 · Kara Whitaker Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 6 July 2027
🇺🇸 US

Who might be able to join this trial: - The mother must be enrolled in a study called the Pregnancy 24/7 Study. - The mother must have completed at least one full 24-hour behaviour assessment, including valid data from a physical activity monitor and completed questionnaires. - The pregnancy must have resulted in the b...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07176403 · Alexandria University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 October 2025
🇪🇬 EG

**Who might be able to join this trial:** - People who have kidney failure and have been receiving regular dialysis (a treatment that filters the blood) for more than three months - People who are older than 18 years of age **Who may not be able to join:** - People who have serious mental health conditions, or who are...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07176767 · Lena Xiao Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇨🇦 CA

Who might be able to join this trial: - Children and teenagers between 8 and 18 years old - People who have had a sleep study showing moderate to severe breathing interruptions during sleep (at least 5 episodes per hour) - People who have recently been prescribed a PAP (Positive Airway Pressure) breathing machine for s...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07179172 · Taipei Medical University Shuang Ho Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 8 November 2025
🇹🇼 TW

Who might be able to join this trial: - Hospital staff between the ages of 20 and 65, or older adults between the ages of 55 and 90. - People who are willing to take part in the full mindfulness course and follow the study's enrollment procedures. Who may not be able to join: - People who have a history of major neuro...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07181122 · Ankara Etlik City Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 26 April 2026
Turkey (Türkiye)

**Who might be able to join this trial:** - People aged 18 or older - People who have been diagnosed with prostate cancer that has spread to other parts of the body and is still responding to hormone-based treatment (confirmed by lab or tissue testing) - People whose treating doctor plans to start them on a type of hor...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07181577 · Aarhus University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 December 2026
🇩🇰 DK

Who might be able to join this trial: - You are between 16 and 24 years old - You have scored above 10 on a standard sleep difficulty questionnaire called the Insomnia Severity Index (ISI), which suggests you may be experiencing significant sleep problems Who may not be able to join: - You have been diagnosed with a n...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07191119 · St. Jude Children's Research Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2027
🇺🇸 US

**Who might be able to join this trial:** - People who survived Acute Lymphoblastic Leukemia (ALL), which is a type of blood cancer - People already enrolled in a long-term follow-up program called SJLIFE - People who were younger than 21 years old when they were diagnosed with ALL - People who are between 20 and 50 ye...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07191314 · University of Michigan Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2027
🇺🇸 US

Who might be able to join this trial: - People who completed the earlier related study (HUM00179497) and want to continue using the NPA-OSA device. Who may not be able to join: - People who did not use the NPA-OSA device as required during the earlier related study. Important: Always verify eligibility with the trial...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07192042 · Taipei Medical University Shuang Ho Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 April 2026
🇹🇼 TW

**Who might be able to join this trial:** - People who are between 20 and 70 years old. - People who have been diagnosed with schizophrenia, schizoaffective disorder, or schizophreniform disorder, confirmed using a standard diagnostic tool called the MINI 7.0 (Chinese version). - People who are in a relatively stable c...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07202351 · Centre Hospitalier St Anne Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 27 February 2026
🇫🇷 FR

Who might be able to join this trial: - People who are 18 years of age or older - People attending a participating addiction treatment centre for help with stopping smoking or cannabis use - People who agree to take part in the study - People who are covered by the French national health insurance system Who may not b...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07207642 · Centre Hospitalier Universitaire de Saint Etienne Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2027
🇫🇷 FR

Who might be able to join this trial: - The patient's legal guardian has not objected to their participation - People aged 60 or older who have been diagnosed with Alzheimer's disease or a related condition - People who are living in a Protected Living Unit (PLU) (confirm with trial site for details on what this means)...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07213349 · Douglas Mental Health University Institute Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 December 2028
🇨🇦 CA

**Who might be able to join this trial:** - People whose memory and thinking test results fall above the threshold for dementia (as measured by standard cognitive tests, such as the MoCA, MMSE, or Clinical Dementia Rating scale) - People who have completed at least 6 years of formal schooling - People who have been on...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07213908 · Children's Hospital Los Angeles Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 February 2030
🇺🇸 US

Who might be able to join this trial: - People between 12 and 18 years old - People who have a sleep health problem, such as trouble falling or staying asleep, a strong preference for staying up late, not getting enough sleep, or generally poor sleep quality - People who are able to participate in a mainstream general...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07216066 · Regeneron Pharmaceuticals Phase 1 · 2 countries Recruiting
Recruiting Phase 1 Est. completion 7 June 2029
🇨🇦 CA🇳🇱 NL

**Who might be able to join this trial:** - People who have been diagnosed with Parkinson's disease according to a specific medical standard, where the diagnosis includes slowness of movement plus at least one other main sign (such as tremor at rest or muscle stiffness), with no other known cause for the condition - P...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07217054 · CND Life Sciences Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2028
🇺🇸 US

**Who might be able to join this trial:** - Men and women between the ages of 40 and 99 who are generally in reasonably good health - People who have been diagnosed with Parkinson's disease (confirmed by a doctor) - People who have been diagnosed with a sleep condition called REM sleep behavior disorder (RBD), as long...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07221318 · Florida International University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2026
🇺🇸 US

Who might be able to join this trial: - Adults between 18 and 45 years old. - People who are able to give written consent to participate. - People who are generally healthy and do not have unstable heart, neurological, or mental health conditions, based on a screening assessment. - People who have been cleared to recei...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07224074 · Johns Hopkins University Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 1 January 2028
🇺🇸 US

Who might be able to join this trial: - Adults between 18 and 50 years old - People with a body mass index (a measure of body weight relative to height) between 18 and 30 Who may not be able to join: - People who have a sleep disorder such as sleep apnea, insomnia, restless leg syndrome, narcolepsy, or a condition cau...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07225088 · Memorial Sloan Kettering Cancer Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2029
🇺🇸 US

**Who might be able to join this trial:** *For mental health providers:* - People who work as mental health providers - People who treat Latino cancer patients and/or survivors - People who have at least 3 years of experience providing mental health or emotional support services to cancer patients and/or survivors - P...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07236229 · Bahçeşehir University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 11 January 2026
Turkey (Türkiye)

Who might be able to join this trial: - People who have been diagnosed with adhesive capsulitis (a shoulder condition sometimes called "frozen shoulder") by a doctor - People whose adhesive capsulitis has been classified as Grade 1 or Grade 2 (confirm with trial site) - People who are receiving physiotherapy for adhesi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07245238 · Khon Kaen University Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 December 2027
🇹🇭 TH

**Who might be able to join this trial:** - People who have been diagnosed with systemic sclerosis (SSc) and are between 18 and 70 years old - People whose SSc was diagnosed using the internationally recognised 2013 ACR/EULAR classification criteria - People who have long-lasting, persistent itching (chronic pruritus)...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07255274 · University of Beira Interior Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇵🇹 PT

Who might be able to join this trial: - A parent or legal guardian must agree to their child's participation, and the young person must also give their own agreement to take part - The young person must be between 13 and 17 years old at the time of signing up - The young person must have been identified as overweight o...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07269483 · Virginia Hawkins Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2026
🇬🇧 GB

**Who might be able to join this trial:** - Adults aged 18 or older who have been referred by a doctor because they may have Obstructive Sleep Apnoea (a condition where breathing repeatedly stops during sleep) - People who are able to understand and agree to take part in the study on their own behalf - People who have...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07273903 · Heinrich-Heine University, Duesseldorf Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2028
🇩🇪 DE

Who might be able to join this trial: - People who have been diagnosed with a specific nerve condition called CIDP (typical or possible typical type), based on recognised 2021 medical guidelines - People who are 18 years of age or older - People who are able to use a smartwatch, as assessed by the trial doctor - People...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07277608 · Capital Medical University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 7 August 2033
🇨🇳 CN

Who might be able to join this trial: - People who have been referred to the sleep centre at Beijing Chaoyang Hospital with a suspected diagnosis of obstructive sleep apnea (a condition where breathing repeatedly stops during sleep). - People who are willing to take part in the study, sign a consent form, and are able...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07280468 · University of Arizona Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 January 2030
🇺🇸 US

Who might be able to join this trial: - People who are 6 years of age or older - People who have a diagnosis of Down syndrome - People of any gender or ethnicity - Adults who do not have a legally authorised representative must have a caregiver or support person who can co-sign consent forms and help complete study que...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT07292610 · University of Castilla-La Mancha Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇪🇸 ES

**Who might be able to join this trial:** - You are between 18 and 25 years old. - You are currently enrolled as a university student. - You are studying in any program at the Cuenca Campus, including Nursing, Social Work, Education, Fine Arts, Engineering, Journalism, or Teaching. **Who may not be able to join:** - Y...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07292922 · Hong Kong Metropolitan University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 January 2027
Hong Kong

Who might be able to join this trial: - Adults aged 18 years or older - People who have been diagnosed with mild to moderate Obstructive Sleep Apnoea, meaning their sleep test showed between 5 and 30 breathing interruptions per hour - People whose doctor has recommended a CPAP machine or a mouth device for their sleep...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07294482 · Efforia, Inc Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 10 September 2026
🇺🇸 US

Who might be able to join this trial: - People who can read and understand English - People who currently live in the United States - People who are willing and able to follow all of the trial's requirements Who may not be able to join: - People who have allergies (confirm with trial site for specifics) - People who a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07294781 · University of Aarhus Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2027
🇩🇰 DK

**Who might be able to join this trial:** - People aged between 23 and 45 years. - People who are able and willing to sign a written consent form agreeing to take part. - People who are fluent in Danish and can understand the study's procedures and instructions. - People who are generally healthy, based on their medic...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07298941 · University of Virginia Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 30 October 2029
🇺🇸 US

**Who might be able to join this trial:** - People aged 18 or older - People who have had low back pain as their main ongoing pain problem for at least 3 months, with pain on at least half of all days over the past 6 months - People whose average pain level has been 4 or more out of 10 over the past week - People who h...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07299578 · University Hospital, Strasbourg, France Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2026
🇫🇷 FR

Who might be able to join this trial: - You are 18 years old or older - You were seen and treated for Ménière's disease in the Ear, Nose, and Throat (ENT) department at Strasbourg University Hospital at some point between June 1, 2019, and January 31, 2021 Who may not be able to join: - You have had surgery inside the...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07299903 · Ankara Yildirim Beyazıt University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2026
Turkey (Türkiye)

**Who might be able to join this trial:** - You are going through menopause. - You are between 40 and 60 years old. - You have been found to have poor sleep quality based on a sleep questionnaire designed for people going through menopause. - You are willing and happy to take part in the study. - You do not have any ph...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07301125 · University of Minnesota Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2027
🇺🇸 US

Who might be able to join this trial: - Adults between the ages of 18 and 65 - People who have recently been diagnosed with obstructive sleep apnoea (OSA), confirmed by a sleep study showing an apnoea-hypopnoea index (AHI) score of 5 or higher (confirm with trial site) - People who have tried a first-line OSA treatment...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07301710 · Uniformed Services University of the Health Sciences Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 September 2027
🇺🇸 US

**Who might be able to join this trial:** - People who have recently been diagnosed with obstructive sleep apnea (OSA), or whose current OSA treatment has not worked well enough - People who are willing to either avoid starting OSA treatment, or stop their current OSA treatment, for 3 months - People who are able to fo...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07319117 · Leeds Beckett University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2026
🇬🇧 GB

**Who might be able to join this trial:** - You are willing and able to sign a consent form written in English - You are between 40 and 60 years old - You are female - You drink caffeine every day - You are generally healthy and do not have any significant physical or mental health conditions **Who may not be able to...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07322276 · Centre Hospitalier Universitaire de Saint Etienne Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 January 2029
🇫🇷 FR

Who might be able to join this trial: - People who do not exercise regularly and tend to spend most of their time sitting or being physically inactive (not meeting the World Health Organization's recommended activity levels) - People who exercise regularly at a regional competitive level, specialising in aerobic activi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07322731 · Yuzuncu Yil University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 May 2026
Turkey (Türkiye)

Who might be able to join this trial: - Babies born early, between 35 and 37 weeks of pregnancy (considered "late preterm"). - Babies who are currently admitted to a neonatal intensive care unit (NICU), which is a specialist ward for newborns who need extra care. - Babies who are in a stable enough condition that a spe...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07331285 · Nyxoah Inc. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2028
🇺🇸 US

Who might be able to join this trial: - People who have a sleep apnea severity score (called an AHI) between 15 and 65, confirmed by an overnight sleep study done within the last 2 years, with specific measurements recorded (AHI4 and ODI4). - Adults aged 22 years or older. - People whose moderate to severe sleep apnea...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07332442 · Yale University Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 January 2030
🇺🇸 US

**Who might be able to join this trial:** - You are able to give your consent to take part in the study. - You have recently been diagnosed with obstructive sleep apnea (OSA), confirmed by a sleep test showing you stop breathing or have disrupted breathing at least 10 times per hour during sleep. **Who may not be able...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07334444 · University Hospital, Strasbourg, France Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇫🇷 FR

Who might be able to join this trial: - Children who have been diagnosed with Down syndrome - Children aged between 0 and 17 years old - Children who had an ear, nose, and throat (ENT) appointment, or a sleep clinic appointment, at the University Hospital of Strasbourg between January 1, 2019, and December 31, 2024 Wh...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07340125 · University of South Carolina Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2026
🇺🇸 US

**Who might be able to join this trial:** - People who are male or female and between 25 and 45 years old - People with a body mass index (BMI) between 25.0 and 34.9, which generally falls in the overweight to moderately obese range - People who score 5 or higher on a standard sleep quality questionnaire called the Pit...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07340268 · Zan Wang Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 November 2026
🇨🇳 CN

Who might be able to join this trial: - People who have been clinically diagnosed with insomnia disorder - People who are willing and able to complete questionnaire surveys as part of the study Who may not be able to join: - People who have a diagnosed mental health disorder - People who are currently using stimulant...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07345065 · De deyne Manon Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2028
🇧🇪 BE

**Who might be able to join this trial:** - Women who have had a single-baby pregnancy (not twins or more) - Women who are between 4 and 12 months after giving birth to their first child - Women who have sleep difficulties, specifically: trouble falling asleep, staying asleep, or waking up too early — AND these sleep...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07345260 · Athletic Greens International Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 April 2026
🇺🇸 US

Who might be able to join this trial: - People who are male or female, between the ages of 35 and 65. - People whose Body Mass Index (BMI) falls between 18.5 and 29.9 (a standard measure of body weight relative to height). - People who are currently having trouble falling asleep, staying asleep, or waking up during the...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07346014 · University of Pittsburgh Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2029
🇺🇸 US

Who might be able to join this trial: - People who are enrolled in, or planning to enrol in, treatment at the COSTAR Intensive Outpatient Program - People who can read and communicate in English well enough to take part in the study activities - People who have had thoughts of suicide or made a suicide attempt in the p...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07349706 · Florida State University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2026
🇺🇸 US

**Who might be able to join this trial:** - You are between 60 and 80 years old - You scored 18 or above on a telephone-based memory and thinking test called the MoCA - You have at least one risk factor for dementia, such as mild memory concerns, high blood pressure, not getting much physical activity (less than 150 mi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07349901 · Getúlio Vargas University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2026
🇧🇷 BR

**Who might be able to join this trial:** - Adults aged 18 years or older - People who are scheduled for a medium or large planned (non-emergency) surgery at HUGV hospital - People who are awake, alert, and able to understand and answer questionnaires and use wearable devices during the study - People who have a basic...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07351006 · Linnaeus University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2026
🇸🇪 SE

Who might be able to join this trial: - People who were born biologically female - People who are between 45 and 55 years old - People who are experiencing menopausal symptoms, meaning irregular or changed periods along with at least one of the following: hot flashes or excessive sweating, sleep problems, mood swings o...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07355842 · University of Zurich Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2029
🇨🇭 CH

**Who might be able to join this trial:** - People who have signed a consent form agreeing to take part - People who have been diagnosed with isolated REM Sleep Behavior Disorder (a sleep condition where a person acts out dreams), confirmed by an overnight sleep study, AND who also either: have early signs of movement...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07357272 · Beijing Anzhen Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2028
🇨🇳 CN

**Who might be able to join this trial:** - People aged between 18 and 70 years old - People who have been diagnosed with obstructive sleep apnea (a condition where breathing repeatedly stops during sleep) through an overnight sleep study, either with a moderate level of breathing disruptions plus symptoms such as day...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07357779 · Zan Wang Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2026
🇨🇳 CN

Who might be able to join this trial: - People who have been clinically diagnosed with insomnia disorder - People who are willing and able to complete questionnaire surveys as part of the study Who may not be able to join: - People who are currently taking medications that stimulate the central nervous system - People...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07370350 · Haute Ecole Bruxelles-Brabant Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2026
🇧🇪 BE

Who might be able to join this trial: - Children and teenagers between 6 and 18 years old - People who have been diagnosed with obesity - People who are already enrolled in the inpatient weight-loss rehabilitation program at the Zeepreventorium - A parent or legal guardian has provided written permission, and the child...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07381504 · National Taiwan University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 July 2026
🇹🇼 TW

Who might be able to join this trial: - The child must be between 3 and 11 years old - The child must have a confirmed diagnosis of Autism Spectrum Disorder (ASD) along with a diagnosed sleep problem Who may not be able to join: - Children who have a genetic or chromosomal condition, such as Down syndrome or Fragile X...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07385105 · University of Missouri-Columbia Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2026
🇺🇸 US

Who might be able to join this trial: - You have been diagnosed by a doctor with a mild traumatic brain injury (such as a concussion) and have had sleep problems for more than 4 weeks - You scored 10 or higher on a standard sleep questionnaire called the Insomnia Severity Index, which measures how serious your sleep di...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07387094 · Hangzhou Sciwind Biosciences Co., Ltd. Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 16 December 2027
🇨🇳 CN

**Who might be able to join this trial:** - People with a Body Mass Index (BMI) of 28 or higher (a measure of body weight relative to height) - People who have had a sleep study that confirms a diagnosis of obstructive sleep apnea (OSA), with a moderate-to-severe level of breathing interruptions during sleep (an AHI s...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07387406 · University of California, Los Angeles Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇺🇸 US

**Who might be able to join this trial:** - People who immigrated to the United States from Korea and currently live in the US - People who can speak, read, and write in Korean - People who are aged 60 years or older - People who score at least 15 on a Korean-language questionnaire measuring the severity of sleep diffi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07387783 · Uskudar University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
Turkey (Türkiye)

**Who might be able to join this trial:** - People aged between 18 and 35 years - People who are willing and able to sign a written consent form agreeing to take part - People who can read, understand, and communicate in Turkish, as all assessments are conducted in that language - People who consider themselves to be i...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07393672 · Washington State University Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 10 November 2026
🇺🇸 US

Who might be able to join this trial: - People who were designated female at birth - People between 40 and 60 years of age - People who are able to give informed consent and do not have an intellectual disability - People whose medication regimen has stayed the same for at least the past 3 months - People who have used...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07399964 · The University of Hong Kong Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
Hong Kong

Who might be able to join this trial: - People who are Chinese and between 12 and 24 years old - People who have been diagnosed with insomnia disorder based on standard diagnostic guidelines (called DSM-V), and who score 9 or higher on a recognised insomnia questionnaire called the Insomnia Severity Index - People who...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07408206 · Northwestern University Early Phase 1 · 1 country Recruiting
Recruiting Early Phase 1 Est. completion 31 October 2026
🇺🇸 US

Who might be able to join this trial: - Adults aged 18 or older who speak English - People who score between 5 and 21 points on a standard anxiety questionnaire called the GAD-7 (this range generally reflects mild to moderate anxiety symptoms) - People who remember their dreams at least once a week - People who are gen...

Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.
NCT07410936 · Nigde Omer Halisdemir University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 August 2026
Turkey (Türkiye)

Who might be able to join this trial: - Female university students currently enrolled in a midwifery or medicine degree program - People aged between 18 and 25 years old - People who have a regular weekly schedule with clear study or work days and free days - People who are willing to take part and sign a written conse...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07411404 · Centre Hospitalier Universitaire de Besancon Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2027
🇫🇷 FR

**Who might be able to join this trial:** - Adults between 18 and 40 years old (both women and men) - People who have signed a consent form agreeing to take part - For the "regular gamer" group: people who have been playing video games at least 3 times a week for the past 2 years, and who score above 5 on a standard ga...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07417813 · Shanghai Mental Health Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 August 2026
🇨🇳 CN

**Who might be able to join this trial:** - People aged 18 or older, of any gender - People who have been diagnosed with a mental health condition of any type, based on standard diagnostic guidelines (called DSM-5) - People whose insomnia has been rated at a score of 11 or higher on a standard sleep questionnaire call...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07419152 · All India Institute of Medical Sciences Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2028
🇮🇳 IN

**Who might be able to join this trial:** - People who are between 18 and 65 years old - People of any gender - People who have been diagnosed with long-term (chronic) insomnia, based on a specific set of recognised medical guidelines (DSM-IV-TR) - People who are able to understand what the study involves and agree in...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07421960 · Uskudar University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 3 April 2026
Turkey (Türkiye)

Who might be able to join this trial: - People who are generally healthy with no significant systemic (whole-body) health conditions - People who have been diagnosed with periodontitis (a serious gum disease affecting the tissues supporting the teeth) - People who have been diagnosed with periodontal health (healthy gu...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07423858 · UMC Utrecht Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 February 2027
🇳🇱 NL

**Who might be able to join this trial:** - People aged 45 years or older who have pain in a hip or knee joint that is related to activity, and whose morning stiffness in that joint lasts no longer than 30 minutes (or no morning stiffness at all), as assessed through a questionnaire based on recognised clinical guidel...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07423988 · University Hospital, Toulouse Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 February 2027
🇫🇷 FR

**Who might be able to join this trial:** *Group 1 – People who work nights at high altitude:* - People who have been employed at the Pic du Midi (a site located at 2,877 metres altitude) for at least one month - People whose job involves working nights at the Pic du Midi as part of their normal duties - People who ar...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07428629 · Dartmouth-Hitchcock Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2026
🇺🇸 US

Who might be able to join this trial: - You have active ulcerative colitis (a type of inflammatory bowel disease), confirmed by a specific scoring tool used in this study - You have trouble sleeping, with a sleep difficulty score above 8, and it takes you more than 30 minutes to fall asleep or you spend more than 30 mi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07432828 · French Cardiology Society Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2027
🇫🇷 FR

**Who might be able to join this trial:** **Patients:** - Adults aged 18 or older who are attending a cardiology appointment. - People who are able to complete a questionnaire. - People who have no objection to taking part. **Cardiologists:** - Cardiologists who previously took part in a study called CARDIOSOM and wh...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07433725 · Baskent University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2026
Turkey (Türkiye)

**Who might be able to join this trial:** - Adults aged 18 or older who have been diagnosed with bruxism (teeth grinding or clenching during sleep and/or while awake), based on a clinical assessment and their own reported symptoms. - People for whom a dentist has determined that a mouth guard (occlusal splint) is appro...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07434050 · Hangzhou Sciwind Biosciences Co., Ltd. Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 19 June 2028
🇨🇳 CN

**Who might be able to join this trial:** - People with a Body Mass Index (BMI) of 28 or higher (a measure of body weight relative to height) - People whose overnight sleep study results confirm a diagnosis of obstructive sleep apnea (OSA), with at least 15 breathing interruptions per hour recorded during screening -...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07438912 · University of Arizona Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 28 February 2029
🇺🇸 US

Who might be able to join this trial: - You are between 18 and 55 years old - You have had thoughts of suicide at some point in the last 6 months - You typically go to bed somewhere between 9:00 PM and 1:00 AM - You typically wake up somewhere between 6:00 AM and 9:00 AM - You are able to give your own consent to take...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07441668 · Ankara Yildirim Beyazıt University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 May 2026
Turkey (Türkiye)

**Who might be able to join this trial:** - Children between 5 and 10 years old - Children who have not received any sedation or anaesthetic medication through a drip in the past 12 hours - Children who are expected to stay in the Paediatric Intensive Care Unit (PICU) for at least 48 to 72 hours - Children who are awa...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07442734 · The First Affiliated Hospital of Zhejiang Chinese Medical University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2026
🇨🇳 CN

Who might be able to join this trial: - People who have been diagnosed with both functional dyspepsia (a digestive condition causing ongoing stomach discomfort) and sleep disorders, based on recognised diagnostic criteria - People who score 7 or higher on the Pittsburgh Sleep Quality Index, a standard questionnaire use...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07444580 · Broad Institute of MIT and Harvard Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 14 August 2029
🇺🇸 US

Who might be able to join this trial: - You are showing clinical signs and symptoms that a doctor believes are consistent with prion disease - You have been diagnosed with "probable prion disease" based on specific recognised medical guidelines (CDC criteria) - You have had a positive result from either a spinal fluid...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07446595 · University of Colorado, Denver Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇺🇸 US

**Who might be able to join this trial:** - People aged between 18 and 75 years old - People with a body mass index (a measure of body weight relative to height) between 25 and 45 - People who have been diagnosed with any type of adult cancer within the past 10 years - People who have finished active cancer treatment...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07446634 · Jani Talvilahti Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2031
🇸🇪 SE

Who might be able to join this trial: - People who have been clinically diagnosed with obstructive sleep apnea (a condition where breathing repeatedly stops during sleep) with a severity score of 15 or more events per hour. - People who live in or are registered as residents in Dalarna County. - People with a body mass...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07450118 · University of Delaware Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇺🇸 US

**Who might be able to join this trial:** - You are 18 years of age or older - You have been told you have prediabetes (confirmed by a blood test in the last 12 months), have previously been diagnosed with diabetes during pregnancy (gestational diabetes), or have screened positive for prediabetes using the Prediabetes...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07457086 · Tarsus University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 August 2026
Turkey (Türkiye)

Who might be able to join this trial: - Adults aged 18 years or older - People who are scheduled to have a surgical procedure called transurethral resection of the bladder (a procedure to remove tissue from the bladder using a small instrument passed through the urethra) - People who are alert, aware of their surroundi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07459764 · Stanford University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 August 2026
🇺🇸 US

Who might be able to join this trial: - People who are between 18 and 30 years old - People who have a regular menstrual cycle that occurs every 21 to 35 days Who may not be able to join: - People who have a disease affecting the muscles or nervous system (such as a neuromuscular or neurodegenerative condition) - Peop...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07464262 · Federal University of São Paulo Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2026
🇧🇷 BR

Who might be able to join this trial: - People aged between 18 and 75 years old. - People who have been diagnosed with severe obstructive sleep apnea (a condition where breathing repeatedly stops during sleep), confirmed by an overnight sleep study showing 30 or more breathing interruptions per hour. - People who have...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07464626 · Dokuz Eylul University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2027
Turkey (Türkiye)

Who might be able to join this trial: - People who are 18 years of age or older - People who have been diagnosed with colorectal cancer - People who are receiving chemotherapy as an outpatient using either the FOLFOX or XELOX treatment regimen - People whose general physical functioning falls within a certain range, me...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07466888 · Seoul National University Bundang Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2026
🇰🇷 KR

**Who might be able to join this trial:** - Adults who are 19 years of age or older - People who score 2 or higher on a questionnaire called the STOP questionnaire, which screens for sleep-related breathing concerns (confirm with trial site) - People who are able to read and write in Korean - People who are willing to...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07470138 · IRCCS Eugenio Medea Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 December 2026
🇮🇹 IT

Who might be able to join this trial: - You have been diagnosed with Autism Spectrum Disorder (ASD) - Your child is between 18 months and 60 months old (between 1.5 and 5 years old) Who may not be able to join: - Your child is currently receiving neurological therapy (treatment related to the brain or nervous system)...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07476937 · University of Pittsburgh Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2030
🇺🇸 US

Who might be able to join this trial: - Children between the ages of 6 and 10 years old - Children whose caregiver has reported an autism diagnosis, and who score above 11 on a standard social communication questionnaire - Children whose caregiver has reported bedtime resistance, with a score above 12 on a specific sle...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07477184 · California Polytechnic State University-San Luis Obispo Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2026
🇺🇸 US

Who might be able to join this trial: - People who are currently working as a CalFire Wildfire firefighter in the Central Coast region, or as a City of San Luis Obispo firefighter (not a volunteer position and not primarily an administrative role) - People who speak English - People who own an iPhone or iPad - People w...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07480109 · University of Texas at Austin Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2027
🇺🇸 US

Who might be able to join this trial: - Women between the ages of 30 and 60 - People with a BMI over 25, meaning they are classified as overweight or obese - People who have been prescribed a GLP-1 medication by a doctor within the last 4 weeks and are currently taking it - People who are able and willing to keep their...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07484217 · Axsome Therapeutics, Inc. Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 December 2028
🇺🇸 US

**Who might be able to join this trial:** - You have been diagnosed with Major Depressive Disorder (depression) without psychosis, confirmed through a structured clinical interview - You experience excessive sleepiness during the daytime - You are able to follow the study procedures and attend required appointments - Y...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07485790 · Amasya University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2026
Turkey (Türkiye)

Who might be able to join this trial: - You are in the last three months of your pregnancy (third trimester) - You are able to read and write in Turkish - You own a smartphone and have access to the internet - You are able to communicate without any barriers - You are willing to take part in the study on your own free...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07486882 · Mayo Clinic Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 March 2027
🇺🇸 US

Who might be able to join this trial: - People aged 22 years or older at the time of screening. - People who have been diagnosed with moderate-to-severe insomnia disorder for more than three months, meaning they have ongoing difficulty falling asleep, staying asleep, or getting good quality sleep. - People who are not...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07497698 · Universidad de Granada Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇪🇸 ES

Who might be able to join this trial: - You are between 18 and 65 years old - You experience mild to moderate sleep problems - Your body weight falls within a moderate range for your height (BMI between 18 and 35) - You are not currently taking medication or receiving therapy specifically for sleep problems - You are w...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07498296 · University of Colorado, Denver Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 November 2026
🇺🇸 US

**Who might be able to join this trial:** - You currently live in Colorado, USA - You have been diagnosed with Parkinson's Disease according to standard medical guidelines - You need little to no help to manage daily activities at home - You have access to the internet - You have a device (such as a smartphone, tablet,...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07498491 · National University of Natural Medicine Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 August 2026
🇺🇸 US

**Who might be able to join this trial:** - Adults aged 18 or older (male or non-pregnant female) - People who have been experiencing pain for at least 3 months - People who rate their average pain over the past week as 3 or higher on a scale of 0 to 10 - People who are physically able to lift a weighted blanket that...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07498712 · Lactomason Co., Ltd. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 27 March 2026
🇰🇷 KR

Who might be able to join this trial: - Adults (both men and women) between the ages of 19 and 65 who are generally healthy - People who score 5 or higher on a standard sleep quality questionnaire called the Pittsburgh Sleep Quality Index, which measures how well someone sleeps - People who have agreed to take part and...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07500090 · Harmony Biosciences Management, Inc. Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 October 2027
🇺🇸 US

**Who might be able to join this trial:** - People who have been formally diagnosed with Idiopathic Hypersomnia (IH) — a sleep disorder causing excessive sleepiness — according to recognised international diagnostic guidelines, with supporting sleep study results on file from within the last 10 years. - People who expe...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07503223 · National University of Malaysia Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2028
🇲🇾 MY

Who might be able to join this trial: - Adults between 18 and 60 years old - People who have sleep problems, based on scoring above 5 on a sleep quality questionnaire called the PSQI, and/or above 15 on a sleep difficulty questionnaire called the ISI (confirm with trial site) Who may not be able to join: - People who...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07519369 · IRCCS San Raffaele Roma Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇮🇹 IT

Who might be able to join this trial: - The person has been diagnosed with autism spectrum disorder (ASD) based on standard medical criteria (DSM-5) - The person is between 2 and 18 years old - The person is able to walk on their own without assistance - The person and their family are willing to have them wear a wrist...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07520786 · University of Georgia Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2026
🇺🇸 US

**Who might be able to join this trial:** - People who are female undergraduate or graduate students - People who are enrolled full-time at the University of Georgia - People who are between 18 and 26 years old **Who may not be able to join:** - People who have a chronic condition such as type 1 or type 2 diabetes, ca...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07522450 · University Hospital, Rouen Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 20 March 2027
🇫🇷 FR

Who might be able to join this trial: - Adults (18 years or older) - People experiencing sudden breathing failure who are being treated with non-invasive ventilation or high-flow oxygen therapy in a critical care unit - People who are awake and conscious at the time of the trial - People who have health insurance cover...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07529626 · Shanghai Zhongshan Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2028
🇨🇳 CN

Who might be able to join this trial: - You must be 18 years old or older. - You must have been diagnosed with pancreatic cancer or another pancreatic condition, confirmed through a tissue or cell sample test. - You must be awake and alert, and be able to read, write, or communicate well enough to answer survey questio...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07530302 · University Hospital, Grenoble Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2029
🇫🇷 FR

**Who might be able to join this trial:** - Adults between 18 and 85 years of age - People who are currently being treated with a ResMed CPAP machine - People whose sleep apnea events are still occurring at a rate of more than 10 events per hour, even while using their CPAP machine - People who have access to a smartp...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07533669 · Sakarya University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
Turkey (Türkiye)

**Who might be able to join this trial:** - You are 18 years of age or older - You are involved in a living kidney transplant as either the person donating a kidney or the person receiving one - Your surgery is planned in advance (not an emergency) - You are mentally alert, clear-headed, and able to follow instructions...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07533799 · Skane University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2033
🇸🇪 SE

Who might be able to join this trial: **People with a sleep condition called RBD (REM Sleep Behaviour Disorder):** - A sleep study has confirmed the RBD diagnosis according to recognised medical guidelines - The person does not have a diagnosis of Parkinson's disease - The person is aged between 50 and 100 years old -...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07540117 · National Health Research Institutes, Taiwan Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2029
🇹🇼 TW

Who might be able to join this trial: - Adults who are 55 years of age or older - People who live independently in the community (not in a care facility) - People who are able to walk on their own, with or without a walking aid such as a cane or walker - People with normal thinking and memory abilities, or only mild me...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07542756 · University of Pennsylvania Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 January 2032
🇺🇸 US

**Who might be able to join this trial:** - Adults between 18 and 80 years of age - People who have been formally diagnosed with Insomnia Disorder based on standard diagnostic guidelines (DSM-5) - People who score 15 or higher on a standard insomnia questionnaire called the Insomnia Severity Index (ISI) - People who ha...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT07544082 · University of Medicine and Pharmacy at Ho Chi Minh City Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2026
🇻🇳 VN

**Who might be able to join this trial:** - People aged 18 years or older who voluntarily agree to take part in the study. - People who have never taken sleep medication, or who stopped taking sleep medication at least 2 weeks before joining the study. - People who have been formally diagnosed with insomnia according...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07547774 · Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospita... Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2026
Turkey (Türkiye)

**Who might be able to join this trial:** - Women between 18 and 70 years of age - People scheduled for planned (non-emergency) breast cancer surgery - People whose overall health before surgery falls within a certain accepted range, as assessed by the anaesthesia team (known as ASA physical status I to III — confirm w...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07550140 · University of Reading Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇬🇧 GB

**Who might be able to join this trial:** - People aged between 60 and 80 years old - People with normal vision and hearing (without aids) - People with a body mass index (BMI) between 18.5 and 30 (a measure of body weight relative to height) - People who have mild to moderate self-reported concerns about their memory...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07551011 · University of the Punjab Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 25 December 2026
🇵🇰 PK

Who might be able to join this trial: - Pregnant women between the ages of 15 and 49 years old. - Those who are between 16 and 20 weeks pregnant at the time of joining the trial. - Those who have been diagnosed with both gestational diabetes (a type of diabetes that develops during pregnancy) and pregnancy-induced high...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07554235 · Jiangsu Taizhou People's Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇨🇳 CN

Who might be able to join this trial: - People aged 65 years or older - People who have both diabetes and high blood pressure - People experiencing sleep problems, as measured by a score of 8 or higher on a standard sleep quality questionnaire called the Pittsburgh Sleep Quality Index - People who are willing to take p...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07558616 · Xuanwu Hospital, Beijing Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 July 2027
🇨🇳 CN

**Who might be able to join this trial:** - People aged between 18 and 65 years who have been diagnosed with either a neuromyelitis optica spectrum disorder (NMOSD) or multiple sclerosis (MS) according to specific Chinese diagnostic guidelines, and who also have insomnia — OR people aged between 18 and 65 who have bee...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07572526 · NYU Langone Health Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 November 2027
🇺🇸 US

**Who might be able to join this trial:** - People who can read and understand study materials written in English, confirmed by a standard reading test score above 85 - People who score 18 or higher on a depression symptom questionnaire (called the MADRS-S) during the screening process - People who have been diagnosed...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07581938 · University of North Carolina, Chapel Hill Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2027
🇺🇸 US

Who might be able to join this trial: - Be between 8 and 13 years old - Be considered generally healthy or have only a mild health condition (as rated by an anesthesia health classification system) - Be able to read and understand English or Spanish - Be able to personally agree to take part, with a parent or legal gua...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07588178 · Yan Fuxia Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇨🇳 CN

Who might be able to join this trial: - People who are 18 years of age or older - People who are already scheduled to have planned (non-emergency) heart surgery Who may not be able to join: - People who have previously had brain surgery, or who have a history of brain conditions such as bleeding in the brain, stroke,...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07601724 · Itshak Amsalem Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2027
🇮🇱 IL

Who might be able to join this trial: - Adults aged 18 years or older - People who are currently in hospital with worsening heart failure and signs of excess fluid buildup in the body - People who have been diagnosed with heart failure (either the type where the heart pumps weakly, or the type where the heart is stiff...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07601841 · Oregon Health and Science University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 12 December 2028
🇺🇸 US

**Who might be able to join this trial:** - Adults between 18 and 89 years of age, of any race, and of any gender - People who speak English - People who can be reached by phone - People who are able to understand and explain the study back to the research team in their own words during the consent process - People wh...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07603583 · Kaohsiung Armed Forces General Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇹🇼 TW

Who might be able to join this trial: - Adults between 18 and 65 years of age - People who have been diagnosed with high blood pressure, including high blood pressure that has been difficult to control with medication - People whose answers to a screening questionnaire (called the STOP-Bang questionnaire) suggest a hig...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07609433 · University of Cyprus Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 31 July 2027
Cyprus🇮🇹 IT

**Who might be able to join this trial:** - Pregnant women between the ages of 20 and 35 - Women who are in their second trimester of pregnancy, specifically between weeks 15 and 27, carrying one baby - Women living in the Catania (Italy) or Limassol (Cyprus) areas - Women who are generally in good health during their...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07611643 · Fondazione Policlinico Universitario Agostino Gemelli IRCCS Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇮🇹 IT

Who might be able to join this trial: - People who are 18 years of age or older - People who are willing to sign a written consent form agreeing to take part - People who have been diagnosed with a jaw joint disorder (temporomandibular disorder) and whose doctor has recommended treatment with a type of dental mouthguar...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07615790 · Fenerbahce University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2026
Turkey (Türkiye)

**Who might be able to join this trial:** - Women who are postmenopausal (have gone through menopause) - Aged between 45 and 65 years old - Able to communicate clearly and work with the research team - Not currently taking part in any organised, structured exercise program - Willing to take part in the study on a volun...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07636850 · Florida State University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 August 2028
🇺🇸 US

Who might be able to join this trial: - Children who are currently enrolled in elementary or middle school (grades 1 through 8) - Children who are between 6 and 13 years old - Children who are able to speak and read in English Who may not be able to join: - Children who have taken antibiotics in the last 3 months - Ch...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07649876 · Milton S. Hershey Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2026
🇺🇸 US

Who might be able to join this trial: - Adults aged 18 or older who are admitted to the Surgical Intensive Care Unit (SICU) at Penn State Health Milton S. Hershey Medical Center - People without serious vision or hearing problems that cannot be corrected (for example, with glasses or hearing aids) - People whose stay i...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07651514 · StudySetGo Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 10 September 2026
🇺🇸 US

**Who might be able to join this trial:** - Adults between 40 and 75 years of age - People who report poor sleep quality, based on a standard sleep questionnaire score above 5 at the screening stage - People who report experiencing leg cramps at night averaging 4 or more episodes per fortnight at the screening stage -...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07656350 · King's College London Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇬🇧 GB

**Who might be able to join this trial:** - Adults between 18 and 60 years old - People who are currently experiencing higher-than-average anxiety, as shown by a score of 10 or more on a standard anxiety questionnaire called the GAD-7 - People who are able and willing to limit their sleep to 4 hours on one occasion du...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07662733 · Shanghai General Hospital, Shanghai Jiao Tong University School of Med... Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 28 February 2027
🇨🇳 CN

**Who might be able to join this trial:** - People aged between 18 and 75 years who are scheduled for a planned (non-emergency) keyhole chest surgery called VATS to remove lung cancer. - People rated as generally healthy or with only mild health conditions, based on a standard anaesthesia health scoring system (ASA cla...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07676110 · soundBrilliance LLC Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇺🇸 US

Who might be able to join this trial: - People who are 13 years of age or older - People who can read, write, and speak English at a 5th-grade level or higher - Adults who are legally able to give their own consent to participate, or children who are able to give their agreement (assent) to participate - People who are...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07682532 · Medipol University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 25 September 2026
Turkey (Türkiye)

**Who might be able to join this trial:** - People who have been diagnosed with Parkinson's Disease and are classified as Stage 1 on the Hoehn-Yahr scale (an early stage of the condition) - People who do not have difficulties with communication or language (such as aphasia) - People who are willing to voluntarily sign...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07685262 · The Hong Kong Polytechnic University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2028
Hong Kong

Who might be able to join this trial: - People who are currently enrolled as a university student - People who are 18 years of age or older - People who are generally healthy and have not been diagnosed with a sleep disorder (sleep quality will be checked using a standard screening tool called the Pittsburgh Sleep Qual...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07698925 · Adly A Adam Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2026
🇪🇬 EG

**Who might be able to join this trial:** - Women between the ages of 25 and 35 who have been diagnosed with Polycystic Ovary Syndrome (PCOS) by a gynaecologist, using a specific set of medical guidelines from 2003 called the Rotterdam criteria - Women whose sleep quality has been assessed using a standard questionnair...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07715721 · Tainan Hospital, Ministry of Health and Welfare Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇹🇼 TW

Who might be able to join this trial: - People who are able to understand and sign a consent form agreeing to take part in the study. - For the older adult groups: People aged 65 or older. - For the general adult group: People aged between 20 and 64. - For the sleep difficulty groups: People who score 5 or higher on a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07723144 · Medical University of Bialystok Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 19 June 2029
🇵🇱 PL

**Who might be able to join this trial:** *For people with obstructive sleep apnea (OSA):* - Adults between 18 and 65 years of age - People with moderate or severe sleep apnea, confirmed by an overnight sleep study showing 15 or more breathing interruptions per hour - People who are willing and able to sign a consent...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Advocacy and support in Australia

Organisations that can offer information, support, or connection for Sleep Disorders. Where more than one is listed, they serve different needs or regions, so choose whichever fits your situation.

The Sleep Health Foundation provides education and advocacy on sleep health broadly, and NODSS provides peer support for narcolepsy and other sleep disorders.

This is a starting point, not medical advice or an endorsement. Contact details change; search the organisation name to find its current website.